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 Temporal lobe epilepsy is the most prevalent form of medication-resistant epilepsy, 
and current electrical stimulation therapy has not been able to accomplish the goal of 
seizure-freedom. This underscores the need for a new target and a different approach with 
more effective neuromodulation for epilepsy treatment. The projections from the medial 
septum (MS) and its regulatory role on the hippocampus make it an attractive 
neuromodulation target. Optogenetics enables selective excitation or inhibition of 
individual genetically-defined neuronal subpopulations, and thus provides a chance to find 
a better target among neuronal subpopulations for inducing a greater therapeutic effect. I 
have exhaustively explored the effect of exciting or inhibiting different neuronal 
subpopulations in the normal rat medial septum by using optogenetic stimulation. As a 
result, MS optogenetic stimulation using hSynapsin promoter in combination with 
Channelrhodopsin-2 was well suited for modulating electrophysiological activity of the 
hippocampus. 
 The conventional approach for preclinical studies requires a large amount of time 
and resources to find effective stimulation parameters and often fails due to the inter-
subject variability in stimulation effect. As an alternative, I presented a novel data-driven 
approach which can optimize the neuromodulation more effectively and efficiently by 
investigating the stimulation effect on the surrogate neural state model. For the new 
approach, I implemented and demonstrated a variety of machine learning techniques to 
explore the stimulation effect, to describe the pathological neural states and to optimize the 
stimulation parameters. Specifically, first, I built a data-driven neural state model to 
xx 
 
estimate a seizure susceptibility based on electrophysiological recordings. The output of 
the model played a surrogate role by providing a metric which was regulated via the MS 
optogenetic stimulation. Second, I further increased the effectiveness of the stimulation by 
implementing in vivo Bayesian optimization which quickly finds the subject-specific 
optimal stimulation parameters. Finally, I tested whether modulating the surrogate neural 
state model affected the symptom of epilepsy (i.e. seizure). The treatment efficacy of the 
data-driven surrogate approach was compared to the stimulation with an empirically 
selected parameter set. The stimulation parameters to maximize the hippocampal theta (4-
10Hz) power, which was a surrogate of the epileptic symptom, was more effective than the 
empirically selected parameter (7Hz) for the seizure suppression.  
 1 
CHAPTER 1. INTRODUCTION 
1.1 Epilepsy and deep brain stimulation 
There is a great need for therapies for epilepsy that lead to high rates of patients 
becoming seizure-free. Epilepsy affects 1% of the world’s population, accounting for a 
large amount of disability and socioeconomic burden 1. Decades of targeted drug discovery 
have improved side effects but have not changed the fact that 30% - or >1 million 
Americans – continue to suffer from seizures despite optimized medication regimes. For 
some patients with medication-resistant epilepsy (MRE), especially those with 
involvement of the medial temporal lobe epilepsy (MTLE), surgical resection may be an 
effective treatment - leading to ~75% of patients becoming seizure free2. Unfortunately, 
risk of neurological deficit, inability to localize the seizures, and/or multifocal seizure 
onsets excludes many patients from surgical consideration. For these patients, electrical 
brain stimulation may provide an effective surgical alternative. There are three types of 
neurostimulation available at this time. The first approved neurostimulation technique was 
vagus nerve stimulation (VNS), which stimulates the cervical vagus nerve projecting 
modulatory effects into the brain. VNS has been shown to decrease seizures in several 
randomized clinical trials (RCTs) by 16-22% (median seizure reduction), increasing to 40-
44% in 3-year open label studies3. The second approved technique is responsive 
neurostimulation (RNS, Neuropace, Mountainview, CA), which decreased seizures by 
median 37.9%4. The third neurostimulation technique is deep brain stimulation (DBS) of 
the anterior nucleus of thalamus (ANT) which demonstrated 40.4% median reduction in 
seizure frequency after 3 months vs. 14.5% in sham-stimulation controls, increasing to 
 2 
57% at 3 years in open-label extension5. However, only few (VNS) and 0 of 247 (RNS) 
patients were seizure-free over the entire 6-year follow-up period. It was also reported that 
only 5.5% (6/109) had a seizure free interval of at least 2 continuous years during the trial 
with ANT-DBS. While MRE patients and their clinicians are very grateful for the 
availability of these treatment alternatives with fewer adverse effects, no such modality has 
yet to achieve the goal of complete seizure freedom. 
1.2 Mesial temporal lobe epilepsy 
We focused our efforts on mesial temporal lobe (hippocampal onset) epilepsy 
(MTLE), for three reasons: 1) MTLE is the most common cause of medication resistant 
epilepsy6. While it is true that there exists effective surgical treatments for MTLE (e.g. 
temporal lobectomy2 or stereotactic ablative procedures7,8), many patients are not 
candidates for destructive surgery due to risks to episodic memory9, or due to bilateral 
onsets. MTLE remains, therefore, a major target population for novel, advanced treatments. 
2) We understand the network involving the limbic structures much better than other brain 
regions10, and, as will become clear, we are taking a network or circuit approach to 
advanced therapy. 3) The results from advances in treating limbic epilepsy will likely be 
transferrable to neocortical epilepsy, as the results in the neurostimulation trials were 
similar in those patients with MTLE and those with extra-MTLE4,5. 
1.3 Optogenetic modulation of septo-hippocampal pathway 
 Medial septum (MS) provides an attractive target to modulate activities of a larger 
hippocampal volume. Successful amygdalohippocampectomy involves resecting a large 
volume of hippocampus to remove the epileptic foci11. However, the volume of neural 
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tissue modulated by electrical stimulation is much smaller than this resected volume12. This 
may be one reason that direct hippocampal electrical stimulation is insufficient to 
completely control seizures. Stimulation of an upstream target which projects to a large 
hippocampal volume is an alternative rational approach. MS in the basal forebrain is highly 
connected to the hippocampus via the fimbria/fornix, thus providing a potential target for 
neuromodulation of hippocampal activity13. 
 Electrical stimulation is non-specific, affecting all neurons within the volume of 
tissue activated while inducing both excitatory14–16 and inhibitory17,18 effects. Optogenetics 
enables selective excitation or inhibition of individual genetically-defined neuronal 
subpopulations19–22, and thus provides a chance to find a better target among neuronal 
subpopulations for inducing a greater therapeutic effect. In a few studies, MS optogenetic 
stimulation successfully modulated hippocampal activity as well as induced behavioral 
change in rodents. Excitation and inhibition of MS GABAergic neurons affected 
hippocampal theta oscillation (type 2 theta) in anesthetized mice, and led to increased and 
decreased object exploration, respectively, in awake animals23. Excitation of MS 
glutamatergic neurons had a stimulation frequency dependent effect on the peak frequency 
of the theta oscillation, and increased locomotion in awake and behaving mice24. In another 
study, excitation of cholinergic neurons slightly suppressed the theta power in freely 
behaving mice while enhancing it under anesthesia25. However, a deeper exploration of the 
effect of MS optogenetic stimulation is required as previous studies focused on a specific 
neural feature (e.g. theta power) and a stimulation parameter which was empirically 
selected. Especially, a comparison of different target neuronal subpopulations combined 
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with various stimulation parameters is required to better understand the septo-hippocampal 
modulation and to induce a desired hippocampal neural activity. 
1.4 Limitation of conventional approach for preclinical studies 
 The conventional approach for preclinical studies for epilepsy treatment has a few 
disadvantages. First, arbitrarily selected stimulation parameters may cause ineffective 
treatment26–29. This leads to the second disadvantage, namely that a tremendous amount of 
resources and time is required to find the right parameter. Third, variability of the 
stimulation effect exists between subjects due to a variation in inherent neural structures 
and the surgical implants, and even within subjects due to non-stationarity of the stimulated 
brain’s neural state. Therefore, the successful neuromodulation treatment in one subject 
does not guarantee another successful one in the other subjects; and subject’s response to 
stimulation can and does vary from time to time.  
1.5 A novel data-driven approach 
 We established a novel data-driven approach using surrogate neural features to 
alleviate the disadvantages listed above. The key components of this method are surrogate 
neural features and intelligent parameter search. First, surrogate neural features allow 
reductions of time and resources required for evaluating the effectiveness of stimulation 
parameters, as observing an immediate response in neural features induced by the 
stimulation is possible. Second, the intelligent parameter search quickly provides the 
subject- and state-specific optimal parameter sets even in a vast parameter space, and thus 
effectively addresses the issue of the variability between and within subjects. 
- Surrogate neural features: What do we modulate? 
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 We modulate epileptic hippocampal neural features as a surrogate of the 
pathophysiological feature (seizure). Investigating neural features offers a few advantages: 
1) a rapid turnaround to evaluate the stimulation effect, 2) early stage disease detection 
(epileptogenesis), 3) a high generalizability as it provides more objective criteria, 4) the 
possibility for prediction of seizures, and 5) a potential to provide insights into underlying 
mechanisms of the disease. Theta power13,30,31 and high frequency oscillations (HFOs)32,33 
are examples of hippocampal neural features well known for their relationship to epilepsy. 
Regardless of decades of research, however, the activity of these neural features has not 
been fully characterized. In addition, a relationship between different neural features has 
not been well explored and we do not know if there exist other neural features which are 
correlated with the pathophysiological feature (seizure). In this project: first, we found 
neural features related to seizures from the hippocampal local field potential (LFP). These 
neural features show how the pathology manifests in neural activity. Second, we built a 
model which provides an output to describe a pathological neural state by using the 
hippocampal LFP. This model translates the activity of epileptic neural features into the 
pathological neural state, so the output of the model plays the role of the surrogate of the 
epileptic symptom, as well as provide a metric (i.e. objective function) which can be 
regulated through MS optogenetic stimulation. With this data-driven approach, therefore, 
we aim to tune the malfunctioning brain region by adjusting its electrophysical activity. 
This approach, which provides a guide to find an effective stimulation method, is valuable 
especially given that the mechanism of epilepsy is not clearly elucidated.  
- Intelligent parameter search: How do we modulate?  
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 The selection of parameters is of obvious critical importance for neuromodulation 
as many studies have shown that the modulation of neural features and behavioral change 
are highly parameter dependent29. However, parameter selection has been done empirically 
and even sometimes arbitrarily in many of the preclinical studies and clinical trials26–28. 
Applying stimulation with the optimal parameters can improve the effectiveness of neural 
feature modulation, but the optimal stimulation parameters are subject-specific due to a 
variability in the stimulation effect between subjects. Exhaustive parameter search methods 
such as a grid search or a random search require a tremendous amount of resource and time 
which also increases the chance of inducing side effects. Therefore, the exhaustive search 
methods are especially not suitable for translational applications which usually demand a 
fast and safe algorithm. In this project, we demonstrated an intelligent parameter search 
algorithm to find the optimal parameters for neural feature modulation. We have 
demonstrated that Bayesian optimization, one of the black-box optimization methods, is 
suitable for finding the optimal parameters for neuromodulation. The optimal stimulation 
parameter was found quickly by applying the Bayesian optimization toolbox, and we were 
able to more effectively regulate the neural features toward desirable.  
1.6 Thesis organization 
Chapter 2: Characterization of the effect of MS optogenetic stimulation in the hippocampal 
rhythms. Machine learning techniques were applied to explore how activating or inhibiting 
multiple MS neuronal subpopulations using different stimulation parameters affects 
hippocampal activities. Methods and results of analyses for finding effective stimulation 
parameters, predominantly modulated neural features and optimizable stimulation 
parameters are presented.  
 7 
Chapter 3: Development of a tool for in vivo neuromodulation parameter optimization. In 
vivo Bayesian optimization was implemented to find the optimal MS stimulation 
parameters to effectively modulate hippocampal neural features. It was demonstrated that 
the optimal stimulation parameters found by the optimization increased hippocampal theta 
and gamma power more effectively than the other stimulation parameters. 
Chapter 4: Development of data-driven surrogate models by characterizing epileptic neural 
features from the hippocampal LFP. A regression and a classifier models were built to 
characterize the neural features during two epileptic neural state transitions: (1) a long-term 
change during epileptogenesis and (2) a short-term change during the pre-ictal period.  The 
output of the models which estimates the seizure susceptibility can play a role of the 
surrogates for evaluating the effectiveness of stimulation parameters. 
Chapter 5: Modification of in vivo Bayesian optimization for effectively modulating 
epileptic neural states with MS optogenetic stimulation. The modified Bayesian 
optimization was applied to find the optimal stimulation parameters to effectively modulate 
the hippocampal theta power and the output of the surrogate model introduced in Chapter 
4.  
Chapter 6: Identification of a causal link between epileptic neural feature modulation and 
seizure characteristics. The treatment efficacy of stimulation parameters found by the data-
driven surrogate approach was compared to an empirically selected stimulation parameter 
set. The optimal stimulation parameters for modulating the surrogate neural features were 
found as described in Chapter 5.  
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CHAPTER 2. CHARACTERIZATION OF THE EFFECT OF 
MEDIAL SEPTUM OPTOGENETIC MODULATION IN THE 
HIPPOCAMPAL RHYTHMS 
2.1 Introduction 
 Given its position within the septo-hipocampal pathway the medial septum (MS) 
has the potential to modulate a large volume of the hippocampus. Thus, understanding the 
functional connectivity of the neurons of the septo-hippocampal pathway can inform future 
stimulation paradigms, similar to how hippocampal deep brain stimulation (DBS) is 
applied to reduce epileptic seizures and enhance memory function5,14,34. However, the 
different neuronal phenotypes, and associated differences in firing patterns and neural 
coding of the various MS neuronal subpopulations, together with a complex network 
connectivity, make the effects of stimulation difficult to predict35. MS has three distinctive 
neuronal subpopulations36–39 that form intricate connections with one another as well as 
their hippocampal targets. The GABAergic MS population selectively innervates most of 
the GABAergic interneurons throughout the hippocampus and thus acts to primarily 
disinhibit hippocampal pyramidal neurons40,41. The glutamatergic MS population 
innervates local MS GABAergic and cholinergic neurons and also directly projects to the 
hippocampal interneurons and pyramidal neurons42–44. Similarly, cholinergic MS neurons 
interact with both MS local neurons45 and hippocampal pyramidal and inhibitory neurons 
in both direct and indirect fashion36,46.  
 Despite initial investigations of MS optogenetic stimulation23–25,47–51, the effect of 
the stimulation on hippocampal activity, particularly in regard to the parameters of 
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stimulation, remains poorly understood and warrants further investigation.  Especially, 
there are a lack of studies comparing the effects on the hippocampal local field potential 
(LFP) activities induced by stimulating different MS neuronal subpopulations. Given the 
varied intrinsic characteristics of MS neuronal subpopulations as well as their complex 
connections, it is expected that the effects and effectiveness of optogenetic stimulation will 
depend in large part on the targeted subpopulation as well as the optical stimulation 
parameters. In addition, understanding the relationship between the parameter space and 
the effects in the hippocampal LFP is essential to identify the optimal parameters for 
purposeful modulation.  
 This chapter mainly describes the methods and results of analyses for characterizing 
the MS optogenetic stimulation effect which were introduced by Park-et-al52. Various MS 
neuronal subpopulations as well as optical stimulation intensities, frequencies and pulse 
widths were explored. A wide range of frequency domain features were extracted from the 
hippocampal LFP for analysis, including power spectral density, coherence and phase 
coherence – the delay of the signal transfer between regions. In a data driven fashion, we 
created a framework to characterize the hippocampal LFP modulated by MS optogenetic 
stimulation. Machine learning techniques were leveraged to analyze large sets of data53,54 
in complex parameter and feature spaces and to provide an objective decision making55–57. 
In order to measure stimulation effectiveness, find predominantly modulated neural 
features, and measure the sensitivity of features to parameter changes, we applied 
classifiers combined with feature analysis and reduction techniques. We also applied a 
regression model which describes a relationship between stimulation parameters and a 
specific feature’s activity. Through this framework, we first quantified the degree of 
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stimulation effectiveness and identified a subset of parameters which induced a substantial 
change in the hippocampal LFP activity. Second, we identified predominantly modulated 
hippocampal neural features through a feature reduction technique. Third, we used 
sensitivity analysis to identify the subset of parameters which can potentially contribute to 
a maximization or minimization of neural features. Lastly, we built a regression model to 
predict the hippocampal theta power change based on the stimulation parameters as a 
model input. Hippocampal theta was chosen based on its well-known relationship with a 
pathological brain state31,58 and cognitive function59 as well as locomotion60. This model 
performed better than the standard linear regression model in describing the non-linear 
relationship between theta power changes and the stimulation parameters.  
2.2 Methods  
2.2.1 Surgical procedures 
 Adult male Sprague-Dawley rats (2-3 month old; 250-300g) from Charles River 
Laboratories (Wilmington, MA, USA) as well as adult male Long-Evans strain rats that 
express the bacterial Cre recombinase under control of the cholinergic choline 
acetyltransferase (ChAT) promoter were used in this study. ChAT rats were bred with 
wildtype animals in-house. Genotyping was performed on tail tissue from 3-week old pups 
using a primer pair according to RRRC (Columbia, MO). Animals from different strains 
were grouped for all analyses. All animals were maintained within a 12/12 light/dark cycle 
vivarium with unlimited access to food and water. All procedures were conducted in 
accordance with Emory University’s Institute for Animal Care and Use committee.   
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 Two surgical procedures were conducted for each subject as described by Laxpati 
et al47. The first survival surgery was for the viral vector injection to MS.  A craniectomy 
(0.40 mm anterior and 2.00 mm lateral to bregma) was made while rats were anesthetized 
with 1.5-4% inhaled isoflurane. Injection of viral vector to MS was made at a 20° angle to 
the dorsal-ventral axis (0.40 mm anterior, 2.12 mm lateral at the 20° angle, 5.80 mm ventral 
to pia along the rotated axis). Once the pipette was withdrawn, the scalp was stapled closed, 
and ketofen was administered as an analgesic (3-5 mg/kg).  For every viral vector, 1.8 µL 
containing ~2×109 viral particles based on qPCR of viral genome was injected using a 
pulled-glass pipette attached to a stereotactically mounted injector (Nanoject, Drummond 
Scientific Co., Broomall, PA, USA).  
 The second survival surgery was conducted after two weeks for recovery and 
optogenetic channel expression. The rats were anesthetized with 1.5-4% inhaled isoflurane 
during the whole surgery. Another craniectomy was made for electrode implantation at the 
right dorsal hippocampus (centered at 3.50 mm posterior and 2.80 mm lateral to bregma). 
Five 2 mm stainless steel screws (Plastics One, Roanoke, VA) were mounted on the skull 
for electrode’s ground and reference wires as well as for structural support. To record from 
both CA1 and CA3, 16-channel multielectrode arrays (MEA; Tucker Davis Technologies 
(TDT), Alachua, FL., USA) were constructed with sixteen 33 µm diameter tungsten 
microwires spaced with 175 µm gap between two wires arranged in two rows offset by 1 
mm. Each row had different length, 4.0 mm and 3.0 mm to target hippocampal CA3 and 
CA1, respectively. The MEA was lowered ventrally into the brain until single unit activity 
was observed from both the CA1 and CA3 regions. After the MEA was placed in the 
desired location, the ferrule was driven into the reopened original virus injection 
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craniectomy at a 20° angle to the dorsal-ventral axis. The fiber was placed where a strong 
stimulus-response signal was observed in the coincident spectrogram at the stimulation 
frequency as well as in the evoked potential, or a depth of 5.80 mm from pia along the 
rotated axis if no response was seen.  Finally, the craniectomy was sealed with dental 
acrylic to secure the electrode and the optic fiber with the ferrule in place in the targets. 
The rats were administered ketofen (3-5mg/kg) and given 3-5 days for recovery before 
starting experimentation. 
 
Figure 1. A. 16 channel multi-electrode-array was implanted in the hippocampus. 
Optic fiber with ferrule was implanted in the medial septum. B. Experimental 
diagram which includes 20 second baseline followed by 20 second stimulation (blue: 
excitation or red: inhibition). C-F. Microscope images of the medial septum to check 
expression of target specific virus (C: hSyn, D: CamKⅡα, E: EF1a-DIO-ChR2 in a 
ChAT-Cre rat and F: EF1a-DIO-eNpHR3.0 in a ChAT-Cre rat). A dotted line 
indicated the area of MS. The scale bar (1µm) was plotted at the bottom right of F. 
2.2.2 Stimulation and recording protocol 
Hippocampal LFPs were recorded at 25 kHz using the NeuroRighter system61,62. 
Square-wave optical stimulation pulses were applied from the NeuroRighter system to an 
implanted ferrule in the medial septum via armored patch fiber cables (200 µm core 
diameter, 0.67 NA, Plexon). Ferrules were calibrated before implanted to have a range 
between 0-100I (1I = 1mW/mm2, 50I equals to 1.57mW). A 465 nm blue LED module was 
used for the excitation and a 620 nm orange LED module was used for the inhibition. The 
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whole parameter sets were tested across 3 different days in each animal. As shown in the 
experimental diagram (Figure 1B), one trial consisted of 20 seconds of excitation with the 
blue light or inhibition with the orange light following 20 seconds of baseline period. 
During the trials, the animals were freely exploring a large open plexiglass enclosure, 
without specific behavioral restrictions or limitations. Between trials, adequate amount of 
time was placed to wash out the post-stimulation effect.  
2.2.3 Description of optogenetic viral vectors and optical stimulation parameters 
 The stimulation parameters that were tested in our experiments are described in 
Table 1. To target different neuronal subpopulation in MS, we used recombinant adeno-
associated viral (AAV) vectors incorporating three different types of promoters (UNC 
Vector Core Services, Chapel Hill, NC, USA): the human synapsin (hSyn) promoter 
pseudotyped with AAV5 is expressed in neurons non-selectively48,63,64, whereas the 
calcium/calmodulin-dependent protein kinase IIα (CamKⅡα) promoter serotyped with 
AAV2 is expressed in glutamatergic neurons;63,64 The Cre-dependent double inverted 
open-frame (DIO) under control of the constitutively active human elongation factor 1α 
(EF1a) promoter pseudotyped with AAV5 was used to produce expression in cholinergic 
neurons in ChAT-Cre transgenic rats65. All viruses were used with either codon-optimized 
channelrhodopsin-2 (ChR2) or an enhanced halorhodopsin chloride pump 3.0 (eNpHR3.0), 
both of which were with a fluorescent tag of enhanced yellow fluorescent protein (EYFP) 
or monomeric Cherry (mCherry). As control for optical stimulation and virally mediated 
transgene expression, EYFP alone was used with the hSyn promoter.  
 All combinations of promoters and opsins composed biological parameters (Table 
1). All seven biological parameters were tested with various optical stimulation parameters. 
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Three different light intensities, seven frequencies ranging from theta to low gamma and 
three pulse widths constituted total 63 stimulation parameters. 
Table 1. A list of optogenetic viruses (biological parameters) for specific target 
subpopulation in MS, stimulation parameters and the number of animals used in 
the experimentation. 
Notes: * 1st Row: intensity, 2nd: frequency and 3rd: pulse width. **1I = 1mW/mm2. 
2.2.4 Hippocampal neural features 
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 Frequency domain features were calculated from 16-channel hippocampal LFP 
recordings. Data were segmented into 20 second baseline and 20 second stimulation epochs 
and down-sampled to 2000Hz. A multi-taper algorithm from MATLAB Chronux toolbox66 
was used for the feature calculation. A detailed description of neural features follows. 
 (i) Power spectral density (PSD) – PSD with 1Hz resolution was calculated in 
0.1-300Hz range. Then the PSD change from the baseline during the stimulation period 
was measured in dB unit. 300 features of PSD change were calculated and averaged for the 
CA1 (Channel 1-8) and the CA3 (Channel 9-16) electrodes separately to generate a total 
of 600 PSD features. 
 (ii) Coherence (Coh) – Coh between CA1 and CA3 was measured in 0.1-300Hz 
range and collapsed into 1Hz bins. Coh was calculated between two facing channels, one 
in CA1 and the other in CA3 (e.g. Channel 1 in CA1 and channel 9 in CA3), and was 
averaged from eight different pairs. The difference of Coh between baseline and 
stimulation period comprised 300 Coh features. 
 (iii) Phase coherence (Phase) – Phase between CA1 and CA3 was measured in 
0.1-300Hz range and collapsed into 1Hz bins. Phase was calculated between two facing 
channels, one in CA1 and the other in CA3, and was averaged from eight different pairs. 
The difference of Phase between baseline and stimulation period comprised 300 Phase 
features. 
 As a result, CA1 and CA3 PSD, Coh and Phase between CA1 and CA3 in 0.1-
300Hz range made up a total of 1200 features. 
2.2.5 Histology 
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 Histology was performed after experimentation to verify the location of the 
electrode and viral vector expression. Rats were transcardially perfused with 0.9% saline 
followed by 4% paraformaldehyde in 0.1M phosphate buffer after they were deeply 
anesthetized with an overdose of Euthasol (5ml/kg, Virbac, Fort Worth, Tx, USA). The 
brain was dissected out and removed after one night being post-fixed with the electrodes 
and ferrules remaining in the head. Then, 50 µm coronal sections were made on a sliding 
microtome and mounted on glass slides with Vectashield DAPI (Burlingame, CA, USA) 
medium for visualization of nuclei. Slides were imaged to visualize the fluorescent tags in 
the opsins with Nikon DS-fil color digital camera on a Nikon E400 microscope using NIS-
Elements software (Nikon Instruments, Inc., Melvile, NY, USA). 
2.3 Results 
2.3.1 Overview of analyses 
 Figure 2 demonstrates the main components of our machine learning framework 
that we developed for characterizing the effect of MS optogenetic stimulation on the 
hippocampal LFP activity. First, controllability was defined by the degree of stimulation 
effectiveness in hippocampal LFP and measured by probing the neural feature activity that 
was distinguishable from the baseline. We used a one-class classification method – positive 
and unlabeled (PU) learning – to compare neural recordings between the effective and 
ineffective trials67. After the classification, the parameter sets were labeled as effective 
(Eff) if they were clearly separable from the baseline; otherwise they were labelled as 
ineffective (Neff). Second, we identified predominantly modulated features by classifying 
Eff and Neff parameters using logistic regression (LR) model classifier with elastic net 
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regularization (ENR, Figure 2C). The regularization with combined L1 (LASSO) and L2 
(Ridge) penalties was used to identify a sparse sub-set of neural features that were 
important for the classification by forcing the coefficients associated with non-significant 
features to be zero68. Selected features by ENR were regarded as predominantly modulated 
features. Third, optimizability of the parameters was defined as how sensitive the 
modulation of neural feature activity was to the change of parameters. A sensitivity was 
measured by an inverse prediction of a modulation parameter from the observed neural 
feature activity, and a higher prediction accuracy indicated a higher optimizability of the 
parameter (Figure 2D). A naïve Bayes Gaussian classifier was applicable for multi-label 
and a categorical variable classification69,70. Fourth, we modeled neural feature activity as 
a function of the optical stimulation parameters with a Gaussian process regression (GPR) 
model, a supervised learning to predict the output by interpolating the observations71. A 
GPR model was selected upon consideration of its ability to describe the non-linear 
relationship and its flexibility as a non-parametric model. 
 18 
 
Figure 2. A. A flow chart of analyses introduced in this study. B. The final labels 
given to each modulation parameter after PU learning classification (right), and the 
initial labels before classification (left). After the classification, all points were 
labeled as effective (Eff) or non-effective (Neff). Although the classification was 
performed in ten-dimensional space, only the first and second principal components 
are plotted for better visualization. C. How ENR was utilized to find a subset of 
neural features which contributed to draw the hyperplane separating Eff and Neff. 
These features were predominantly modulated by the stimulation. D. The scheme of 
the inverse parameter prediction to evaluate the neural feature’s sensitivity toward 
each parameter. Accurately predicted parameters were regarded as having a higher 
optimizability as features were sensitive to their change. E. A GPR model was built 
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to describe a relationship between parameters (input) and neural feature activity 
(output).  
2.3.2 Controllability 
2.3.2.1 Building a classifier for controllability measurement 
 Using the controllability test, we identified the stimulation parameters that 
effectively modulated the hippocampal neural features using the PU learning one-class 
classification67 with a support vector machine (SVM). A SVM was selected to avoid the 
overfitting by controlling the margin of the hyperplane (i.e. support vectors). This 
characteristic of a SVM can contribute to a high performance in a classification problem 
with a moderate number of samples72,73. The classification procedure is described in Figure 
3. One single point was constituted by averaging the feature sets from multiple trials of the 
same parameter set. Likewise, 10 trials of the 40-second baseline recording without 
stimulation constituted one single point by averaging the features. To avoid inaccurate 
classification and a high computational burden caused by the high dimensionality of the 
feature space, principal component (PC) analysis was applied to reduce the dimension of 
the features. Ten PCs were used as features for the classification. At the beginning of the 
classification, the baseline recording exemplars were assigned to the P class. The rest of 
the data set that contained the stimulation exemplars were kept as unlabeled (U). The 
Euclidean distance from the center of P in the reduced feature space was measured for 
every point in U. Points among U which were distant from the center of P were assigned 
as initial negative class labels (N) to initialize the classification process. A SVM classifier 
with a linear kernel was trained with the points from P and N classes. Then, the classifier 
was applied to U, and the points classified as negative were newly assigned to N (Figure 
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3B). A new SVM classifier was trained and applied to the unlabeled points iteratively until 
no new assignments to N were made (Figure 3A). After the last iteration, points remaining 
as unlabeled were assigned to P class (Figure 3C).  
 The final labels for the controllability test, either Eff or Neff, were identified 
according to the result of repeated PU learning classifications. As iteration went on during 
the PU learning, N class outnumbered P class, which resulted in an unbalanced dataset for 
classification. To address this issue, we subsampled the points from the outnumbered class 
(N) through a random selection. The whole classification was repeated 100 times so that 
the points from the outnumbered class can be further exploited and thus the loss of 
information caused by subsampling is minimized74. During the repetition, each point was 
classified to the baseline class (P, Figure 3 blue) or the stimulation class (N, Figure 3 red). 
The final label of either Eff or Neff was decided by thresholding. Eff was assigned to a 
parameter classified to the stimulation class more than 60 times out of 100 classification 
(0.6017, 95% upper confidence bound based on the binomial distribution).  
Other points that could not reach the threshold were labeled as Neff. After all the points 
were labeled, we validated the labels by testing if two classes were separable through a 
cross validation (CV) with a SVM classifier. In addition, various numbers of PCs were 




Figure 3. Parameter labeling using the PU learning. A. The portion of positive, 
negative and unlabeled points as the iteration goes on. A SVM classifier is trained 
with the labeled points every iteration (Iter) and applied to the unlabeled points. 
Iteration ends when the SVM classifier does not find a new negative point.  B. An 
example of a hyperplane separating the positive and negative labeled points after 
the first iteration. The unlabeled points belonging to the same side with the 
negatives are newly assigned as negative. C. An example of a hyperplane at the last 
iteration when there are no new negative points detected. The unlabeled points 
belonging to the same side with the positives are assigned as positive. 
2.3.2.2 Neurological frequency band power statistical test 
 We measured the power change in the neurophysiological frequency bands (Delta: 
1–3Hz, theta: 4–10Hz, alpha: 10–16Hz, beta: 16–31Hz, low gamma: 32–60Hz and high 
gamma: 60–100Hz) induced by the stimulation to validate the controllability test result. 
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The difference of the power in each band between the stimulation and the pre-stimulation 
period was calculated in dB scale. The power change in the baseline activity without the 
stimulation was also calculated in the same way. A two-sample t-test without assuming the 
equal variances of the populations was performed between the power change from the 
recordings without the stimulation and recordings belonging to each parameter set.  
Parameter sets which rejected the null hypothesis were identified for each frequency band 
(p < 0.05, Bonferroni corrected for multiple comparisons). 
2.3.2.3 Controllability test results 
 We first performed a controllability test to measure the degree of stimulation 
effectiveness for all parameter sets and validated the results with the statistically tested 
change in the neurophysiological frequency band powers. The outcome of the 
controllability test showed that of a total of 441 parameter sets, 91 were labeled as Eff and 
the other 350 were labeled as Neff  (Figure 2B, Figure 4A). We found that two biological 
parameters provided the most effective hippocampal modulation. Specifically, hSyn-ChR2 
and CamKⅡα-ChR2 exhibited 55 and 36 Eff parameter sets respectively (Figure 4A) of 63 
total parameters in the controllability test. The frequency band statistical test also revealed 
that hSyn-ChR2 and CamKⅡα-ChR2 showed the biggest stimulation effect (Figure 4A). 
The other biological parameters did not induce any substantial stimulation effect. The high 
accuracy (99.1%) of the cross-validated classification between the neural feature activity 
induced by Eff and Neff further supported the controllability test results as well as the 
methods including the selection of the SVM classifier.  
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 In addition, we observed that the stimulation intensity was the dominant factor in 
modulating neural state, and the frequency and the pulse width affected activity of neural 
feature only when the intensity was low. In hSyn-ChR2 trials, every stimulation parameter 
effectively modulated the hippocampal activity when the intensity was above 30I (Figure 
4B). When the stimulation intensity was low (=10I), low frequencies (5, 7 and 11Hz) did 
not show any substantial effect (Figure 4B). This was even more pronounced when the 
pulse width was shorter (=2ms) (Figure 4B). Moreover, high frequency stimulation 
(>17Hz) was always effective regardless of the intensity or pulse width. In contrast, in 
CamKⅡα-ChR2 animals, lower intensity (=10I) was always ineffectual (Figure 4B). 
However, when the intensity was 30I, all the frequencies above 11Hz effectively 
modulated neural features while low frequency parameter sets (5–11Hz) did not (Figure 
4B). 
 LFP traces were shown to illustrate the effect of the stimulation (Figure 4C and D). 
Two stimulation parameters identified as Eff (hSyn-ChR2 7 and 42Hz with 50I-10ms, 
Figure 4C) were contrasted with two Neff parameters (hSyn-ChR2 10I-7Hz-10ms and 
hSyn-eNpHR3.0 50I-7Hz-10ms, Figure 4D). The effect of the stimulation characterized by 
the evoked potential was noticeable only in the stimulation with Eff parameters.  
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Figure 4. A. Controllability of the hippocampal LFP biomarkers was measured and 
compared with the t-test (p=0.05, Bonferroni corrected) result of the conventional 
neurophysiological band power for a validation purpose. The number of stimulation 
parameters labeled as Eff (controllability) was indicated in the bar graph after 
grouped by the biological parameter along with the number of stimulation 
parameters which had significant power change in each frequency band. B. Labels 
(color: Eff and blank: Neff) for individual stimulation parameter set for hSyn-ChR2 
and CamKⅡα-ChR2. The other biological parameters were not shown as they did 
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not have Eff labels. C-D. LFP examples of Eff parameters (C) and Neff parameters 
(D). 
2.3.3 Predominant neural features 
2.3.3.1 Identification of predominantly modulated neural features  
 After labeling the stimulation trials, a LR classification model with ENR was 
trained to identify predominantly modulated neural features. The model was trained to 
classify Eff and Neff samples, and ENR forced the model to only select the important 
features. The model was trained with 80% of the total data and tested with the remaining 
20%.  Equation 1 shows the cost function that was used for training the classifier. In 
Equation 1 the alpha determines the ratio between L1 and L2 penalties and the lambda is a 
weight of the regularization. A nested CV was performed to train and test the classifier 
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 In the inner layer, 5-fold CV was conducted and a set of alpha and lambda (Equation 
1) that provided the lowest deviance was found through a grid search (alpha: 0-1 and 
lambda: 0.0001-10). In the outer layer the model was trained with the selected 
hyperparameters transferred from the inner layer. The coefficients of the model were saved 
for every 5-fold CV in the outer layer. This nested 5-fold CV was repeated 10 times 
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resulting in a total of 50 sets of model coefficients. The modulated features were finally 
identified by the following criterion. Features were selected if their model coefficient was 
non-zero whereas features with zero coefficient were abandoned. Thus, the selected ratio 
indicated how often features had the non-zero coefficient. Finally, predominantly 
modulated neural features were identified if its selected ratio was significantly above the 
chance. 
 The most predominant neural feature was compared to the theta band (4-10Hz) PSD 
regarding their degree of effect and chance of being modulated by Eff parameters. The 
degree of the effect was defined by measuring the mean of the feature change divided by 
the feature’s baseline variation.  The chance of modulation was defined by finding a ratio 
of parameters which induced a significant feature change among all Eff parameters. A t-
test was conducted to identify the significant feature change (p < 0.05, Bonferroni corrected 
for multiple comparisons). 
2.3.3.2 Power spectral density was predominantly modulated 
 We applied ENR to identify the neural features that were predominantly modulated 
by MS stimulation. The Power Spectral Density (PSD) of the LFPs in CA1 and CA3 were 
more noticeable than those of coherence (Coh) and phase coherence (Phase) between CA1 
and CA3. First, the frequency range of the predominant PSD features was wide-spread for 
both CA1 and CA3 (Figure 5A-B).  In CA1, the PSD for high beta and low-gamma bands 
were identified as predominantly modulated with the peak of the fitted line observed at 
45Hz – a low-gamma wave (Figure 5A). In CA3, the PSD for delta, theta, high-beta and 
low-gamma bands were predominantly modulated with the peak of the fitted line similar 
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to the one found in CA1 (45Hz, Figure 5A). Coh and Phase did not show any predominance 
(Figure 5C-D) and were therefore dropped from further analyses.  
 Differences of predominantly modulated neural features between stimulation in 
hSyn-ChR2 and CamKⅡα-ChR2 animals were observed (Figure 5A-B) when we applied 
ENR to each group separately. The stimulation with CamKⅡα-ChR2 induced significantly 
more effect in the high beta band (28-33Hz) PSD in CA1. In contrast, the low-gamma band 
(38-50Hz) PSD in CA1 and the mid-gamma band (63-73Hz) PSD in both CA1 and CA3 
showed higher predominance in hSyn-ChR2 animals. 
 
Figure 5. Predominantly modulated neural features. A-D. Selected ratio from 
repeated ENR (0.1–300Hz, a black dot indicates the mean value and the error bar 
indicates 95% confidence interval) with a fitting line and the 95% confidence 
interval (black, the confidence interval was indicated by the shaded area) was 
plotted. The result of separately applying ENR to hSyn-ChR2 (red) and CamKⅡα-
ChR2 (blue) was superimposed. E-F. Comparison of stimulation effect in theta (4-
10Hz) and predominantly modulated (40-50 Hz) band PSD in CA1 and CA3.  The 
predominant band PSD was largely affected by the stimulation except CamKⅡα-
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ChR2 in CA1 (E), and more stimulation parameters induced a substantial change in 
the predominant band PSD than theta (F). 
 
 The predominant neural feature (40-50Hz – low gamma band PSD) was largely 
affected by a higher number of stimulation parameters compared to the theta band (4-10Hz) 
PSD (Figure 5E-F). The predominant neural feature was selected to be centered at 45Hz – 
the most predominant both in CA1 and CA3 PSD. The degree of modulation effect, 
measured by the normalized mean of the feature changes, showed that the stimulation 
induced a larger change in the predominant neural feature than the theta band except 
CamKⅡα-ChR2 in CA1 (Figure 5E). More Eff parameters induced a significant change in 
the predominant neural feature than in the theta band PSD (Figure 5F). The high ratio 
(>0.88) showed that almost every Eff parameters induced a significant change in the 
predominant neural feature.     
2.3.4 Optimizability 
2.3.4.1 Optimizability measurement 
Optimizability of the stimulation parameters – a sensitivity of neural feature activity 
toward the parameters – was measured to identify the most useful parameters to modulate 
the neural feature activity. A Gaussian classifier which is a subtype of the naïve Bayes 
classifiers was capable of multi-input-multi-output classification for inverse parameter 
prediction with observed neural feature activity69,70 (Figure 2D). The process of prediction 
with the Gaussian classifier was designed to minimize the risk of incorrect prediction 
(Equation 2). Then, according to Bayes theory, the optimal decision was to select the label 
which maximized the likelihood (Equation 3, ML: maximum likelihood). The likelihood 
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of a parameter set with the observed neural activity was calculated based on an underlying 
assumption that the features followed multivariate Gaussian distribution with the uniform 
prior (Equation 4). A sparse inverse covariance matrix adapting the L1 regularization75 
technique was used to moderate the problem of an inaccurate prediction caused by the 
interdependencies in a high dimensional feature space. 
 𝑔





𝑔(𝑥): decision function and 𝑔∗(𝑥): optimal decision  
𝐿[𝑔(𝑥), 𝑦] =  {
1, 𝑔(𝑥) ≠ 𝑦
0, 𝑔(𝑥) = 𝑦
 
(2) 

















−1(𝑥 − 𝜇𝑖)} 
𝑤ℎ𝑒𝑟𝑒 𝑃𝑌(𝑖) = 𝐶 (𝐶𝑜𝑛𝑠𝑡𝑎𝑛𝑡) (4) 
 Leave-one-out classification was performed to predict a set of four parameters used 
in a single trial while the other trials contributed to the probability distribution described 
in Equation 4. A mean and a covariance matrix were calculated with the training data, and 
a parameter set for a test trial was predicted by the trained Gaussian classifier. This process 
was separately performed for two groups (Ntrial,Eff = 1789, Ntrial,Neff = 5919) to contrast the 
prediction availability of Eff and Neff classes. A prediction accuracy was calculated for 
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individual parameters by checking that a specific parameter was correctly predicted 
regardless of how the other parameters were predicted. 
2.3.4.2 Optimizability test results 
 Neural features demonstrated sensitivity to biological parameters and stimulation 
frequency as indicated by their high accuracies of inverse parameter prediction with a 
Gaussian classifier at 75.91% and 93.8% respectively (Figure 6A).  In contrast, neural 
features showed less sensitivity to intensity and pulse width with prediction accuracies of 
only 50.64% and 41.25% respectively (Figure 6A). These results contrasted with the 
predictions obtained with the Neff parameters which demonstrated a low prediction 
accuracy for all parameters (<30%, Figure 6A). 
 The prediction accuracies of hSyn-ChR2 and CamKⅡα-ChR2 suggested that both 
biological parameters induced clearly distinguishable effects on neural features (Figure 
6B). Similarly, the high prediction accuracies for all frequencies showed that frequencies 
also induced strongly distinguishable effects on neural features (Figure 6B). Moreover, the 
lower prediction accuracies of intensity and pulse width showed that neither of these 
parameters induced noticeably different modulation effects on neural features. This implies 
that neural features were only sensitive to biological and frequency parameters, so they are 
useful parameters to control neural activity.   
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Figure 6. Inverse parameter prediction accuracies in optimizability test. A. The 
mean and the confidence interval of the accuracy of the prediction grouped by each 
parameter (blue). The prediction result of parameters from Neff class was shown 
for a comparison purpose (red). The higher accuracy of biological parameter (B-
param) and frequency prediction indicates that neural features are sensitive to these 
parameters.  B. The accuracy for individual component of the parameter groups.  
2.3.5 Stimulation parameter - hippocampal theta modeling 
2.3.5.1 GPR modeling 
 We used regression modeling to describe the hippocampal theta activity as a 
function of the MS stimulation parameters. We modeled the change in the hippocampal 
theta power in CA1 and CA3 from the baseline as a function of the stimulation parameters 
using the three-dimensional GPR model for each biological parameter. The theta band (4-
10Hz) power was calculated by the sum of the area under PSD curve, and its change from 
the baseline to the stimulation period was calculated in dB level. We used a constant zero 
mean and a third order Matern kernel covariance function with automatic relevance 
detection76 to train the GPR model (Equation 5).   
 
𝑘(𝑥𝑝, 𝑥𝑞) = 𝜎𝑓
2(1 + √3𝑟)exp(−√3𝑟) 
(5) 
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 The hyperparameters of the covariance and the likelihood function of the GPR 
model were optimized to minimize the negative log-marginal-likelihood of the 
observations. The model was trained with 90% of the whole data and tested through 10-
fold CV with 10 repetitions. A standardized mean squared error (SMSE) between the 
model output and the observed theta power change was calculated to measure the 
goodness-of-fit (Equation 6) with the test data. 
 








𝑦𝑗: observed value and ?̂?𝑗: model output (6) 
 Also, the variance of the model output was calculated to measure the variability of 
the model with the test data.  The learning curve of the model was calculated by repeatedly 
measuring SMSE while increasing the number of training data to monitor the improvement 
of the model. The convergence criterion was defined as when the SMSE value was 
confined within the 1% range of the final value at the end of the training. The performance 
of the GPR model was compared to a linear regression (LnR) model to test the non-linearity 
of the relationship between the stimulation parameters and the change in the hippocampal 
theta power. 
2.3.5.2 Hippocampal theta power changes as function of stimulation parameters 
 The GPR model for hSyn-ChR2 and CamKⅡα-ChR2 described the non-linear 
relationship between the stimulation parameters and changes in theta power. The higher 
output variance and the lower SMSE of the hSyn-ChR2 and CamKⅡα-ChR2 models 
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indicates their good performance in predicting the change in theta power in CA3 (Figure 
7A-B). In contrast, hSyn-eNpHR3.0, CamKⅡα-eNpHR3.0, ChAT-ChR2 and ChAT-
eNpHR3.0 models resulted in a variance of 0 and SMSE of 1 (Figure 7A-B) indicating that 
these latter models were unable to describe the relationship between the parameters and 
theta power (Figure 7A-B). 
 
Figure 7. The validation of GPR model and examples of an application for finding 
the optimal parameters. The model describes the relationship between stimulation 
parameters and changes in hippocampal theta power (4–10Hz) A-B. SMSE and the 
variance of the GPR model output for every biological parameter in CA1 and CA3. 
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C-D. Learning curves of the GPR model with the growth in the number of training 
data. The learning curves of LnR model plotted for a comparison purpose. The 
black triangles indicate the converged points. E-F. Theta power change for two 
stimulation parameters to tract the origin of SMSE by comparing the variability 
between trials and animals. G. Theta power in CA3 GPR model of hSyn-ChR2 on 
the frequency-pulse width plane. H. PSD of hSyn-ChR2 when stimulated with 
maxparam (50I-5Hz-2ms, red) and minparam (50I-42Hz-10ms, blue) compared to 
the baseline (black). I. Theta power in CA3 GPR model of CamKⅡα-ChR2 on the 
frequency-pulse width plane. J. PSD in 0.1–50Hz of CamKⅡα-ChR2 when 
stimulated with maxparam (10I-5HZ-5ms, red) and minparam (50I-42Hz-10ms, 
blue) compared to baseline (black). 
 A comparison between the learning curves of the linear and non-linear models for 
the hSyn-ChR2 and CamKⅡα-ChR2 showed that the GPR model captured the non-linear 
relationship between the activity of neural features and the stimulation parameters (Figure 
7C and D). Following a certain amount of training data (>100 samples), GPR models 
performed better compared to LnR models, and such difference in performance can be 
attributed to the GPR model’s ability to describe non-linear relationships. For example, a 
GPR model was able to demonstrate the non-linear relationship between changes in theta 
power in response to varying frequencies at lower intensity (Figure 7G, left). The 
convergence points in the learning curves indicated that the GPR models required more 
training data compared to the LnR models (Figure 7C and D). 
 A variability of the stimulation effect on the theta power in CA1 and CA3 was 
compared to tract the origin of the error of the GPR model represented by SMSE. The theta 
power change in CA1 and CA3 induced by four Eff parameters (hSyn-ChR2 & CamKⅡα 
-ChR2 combined with 50I-7Hz & 35Hz-10ms) is shown in the box plot for every animal 
(Figure 7E-F). The box and whisker plots indicated a high variance between trials within 
the same animal (Figure 7E-F). The variability between animals was significant only in 
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one (hSyn-ChR2, 50I-7Hz-10ms in CA3) out of 8 parameters according to ANOVA test 
(F2,46 = 13.3, P<0.0001).  
2.4 Discussion 
 Despite extensive studies describing the involvement of MS in the septo-
hippocampal pathway, the precise mechanisms by which subpopulations of neurons in the 
MS modulate hippocampal LFP activity remains largely unknown. The lack of this cell-
type specific exploratory analysis of the septo-hippocampal pathway modulation hinders 
the selection of optimal stimulation parameters for neural feature and potentially behavioral 
modulation. In the present study, we exhaustively tested combinations of MS stimulation 
parameters, including seven different biological parameters, and applied machine learning 
techniques to characterize their effects on neural features from hippocampal LFPs. The 
results demonstrate that only two of the MS biological parameters in combination with sets 
of optical stimulation parameters induced significant changes in LFP (Figure 4). Further 
analysis identified low-gamma frequency PSD as the predominantly modulated neural 
features in LFPs while coherence and phase coherence were only marginally modulated 
(Figure 5). Manipulation of the biological parameters and stimulation frequency were 
revealed to be most useful when optimizing the neural feature modulation (Figure 6). 
Lastly, the GPR model performed better than the linear model in describing the relationship 
between neural features and parameters and was consistent with the previous analyses 
(Figure 7). As a conclusion, these results emphasized that a selection of an optogenetic 
virus as well as stimulation parameters is important to induce a desired neural activity. 
 The results and techniques developed in this chapter were leveraged in the 
following chapters. First, as a result of the controllability test we used hSyn-ChR2 for the 
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further studies as it provides the maximum controllability on the hippocampal activities. 
Second, we will explore a broad space to find epileptic neural features as MS optogenetic 
stimulation modulates not only the hippocampal theta power but also the other frequency 
band power. Third, the frequency axis will be mainly explored to find the optimal 
parameters as it provided the highest optimizability. Fourth, the parameter space explored 
in this chapter did not provide the effective theta power increase so a broader parameter 
space will be tested.  
2.4.1 Origin of variations in controllability 
 Variation in controllability can stem from the diverse characteristics of light-driven 
ion channels and MS subpopulations. In animals injected with hSyn-ChR2, intensity was 
the most dominant factor for controllability, and frequency and pulse width contributed 
only when intensity was low. Raising light intensity increased not only the number of 
neurons stimulated but strength of the induced current of each neuron, likely accounting 
for the intensity being a major factor for controllability. Higher intensity can penetrate 
deeper within the tissue, potentially recruiting more of the transduced MS neurons to fire22. 
Higher intensity also likely increases the percentage of channels recruited within a given 
volume. In addition, according to an in-vitro study of neurons expressing ChR2, a positive 
relationship was found between intensity and the peak amplitude of the induced current at 
the channel level77. The fast firing rate of GABAergic and glutamatergic neurons that were 
transduced with the hSyn promoter may allow for a robust response from the high 
frequency stimulation. Previous studies have shown that GABAergic neurons78 (12–39Hz) 
and glutamatergic neurons79 (12–17Hz) have a faster firing rate than cholinergic neurons78 
(0.3–0.5Hz) in MS. We also showed that pulse width, which is also positively related to 
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the peak amplitude of the induced current at the channel77, significantly affected the 
controllability of the neural features when the intensity of the stimulation pulse was low. 
In this study, the inhibition with using short pulses with eNpHR3.0 did not affect the 
hippocampal LFP substantially even at the longest pulse width (20ms) and the highest 
frequency (42Hz) that we tested. Several studies including a lesion and a pharmacological 
block of MS attenuated or completely disrupted the hippocampal theta power24,80,81. These 
studies taken together with ours suggest that inhibition in the MS needs to be prolonged or 
chronic to affect the hippocampal oscillations in the hippocampus.  
 In the case of CamKⅡα-ChR2, in accordance with the results from hSyn-ChR2, 
intensity was the most important factor for controllability, likely involving similar 
mechanisms. In CamKⅡα-ChR2 experiments, the frequency also affected the 
controllability when the intensity was low; high frequency stimulation demonstrated higher 
controllability. We suspect that the specific activation of fast firing glutamatergic neurons 
in MS was responsible for this, although it is unclear if they are primarily acting through 
direct projections to the hippocampus, or via local synapses on GABAergic MS 
projections.  
 In our studies using the cholinergic specific expression of both ChR2 and 
eNpHR3.0, we observed only a marginal stimulation effect on hippocampal LFPs with MS 
modulation. MS cholinergic neurons are characterized by their low spontaneous firing rate 
which may explain their negligible stimuli response78. In addition, several studies suggest 
the cholinergic projections are largely acting through muscarinic receptors, which would 
not demonstrate the same frequency-specific stimulation response as seen with GABAergic 
and glutamatergic neurons82.   
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2.4.2 Hippocampal low-gamma power as predominantly modulated neural feature 
 The low-gamma spectral band power in CA1 and CA3 was predominantly 
modulated by the MS optogenetic stimulation. This was in contrast with previous studies 
which have proposed a correlation between MS and hippocampal theta power. Previous 
lesion studies and electrophysiological findings40,45,80,83,84 suggested a role of MS as a 
pacemaker for the hippocampal theta rhythm. However, within our parameter space, both 
hSyn-ChR2 and CamKⅡα-ChR2 stimulation more predominantly modulated the low-
gamma band power. This suggests that the effect induced by the external brain stimulation 
is different from the one expected based on the lesion study and the natural brain dynamics. 
Together with a previous study which showed that a pharmacological block of MS 
suppressed post-ictal hippocampal gamma wave85, our study emphasizes the role of MS in 
the modulation of hippocampal gamma rhythm. These results also suggest a gamma-related 
mechanism by which MS stimulation may be able to affect memory performance given 
their well-known relationship86,87. 
2.4.3 Optimizable MS stimulation parameters for modulating the hippocampal neural 
features 
 Measuring optimizability – the sensitivity of neural feature activity toward the 
change of parameters – can provide an efficient way to optimize the modulation of neural 
feature activity. The complex anatomical structure of the septo-hippocampal system makes 
the effects of stimulation hard to anticipate. Finding a desired parameter set therefore 
requires a tremendous amount of resources exploring an infinite parameter space. By 
utilizing optimizability tests, we can identify sub-regions of the stimulation parameter 
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space for targeted exploration by identifying unimportant parameters, such as intensity and 
pulse width.  
 In our studies, results from the optimizability test were somewhat different than 
those from the controllability test. For example, although the stimulation intensity highly 
affected the controllability, it did not impact optimizability in the neural feature activity. 
One possibility is that intensity plays a thresholding role (like a switch) in the induction of 
the stimulation effect. On the other hand, frequency played a secondary role in the 
controllability, but was highly useful for inducing various neural feature activities. 
Therefore, to optimize neural feature modulation it is best to explore the stimulation 
frequency space while setting the intensity at a high level. 
2.4.4 Modeling relationships between stimulation parameters and the hippocampal 
neural features 
 The stimulation parameter-neural feature relationship revealed by the GPR model 
was consistent with the controllability and optimizability results. In addition, the variation 
of neural feature activity along the frequency axis was much higher than along the pulse 
width axis (Figure 7G and I) which agrees with the optimizability test result. 
 The variability in the neural feature modulation represented by SMSE (Figure 7A, 
C and D) suggested a state dependency of the stimulation effect. The theta power change 
induced by the stimulation was different for every trial, and this variance was more 
noticeable than the variance between animals (Figure 7E-F). This is in line with several 
studies indicating that a variation in stimulation effect can come from the internal brain 
state as well as from the behavioral state. We have previously shown that the impact of 
local hippocampal stimulation88 and MS optogenetic stimulation89 can be predicted by 
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hippocampal LFP activity. Moreover, Vandecasteele et al. also described that MS 
stimulation effect can be modulated by ripple events in the hippocampus25. The behavioral 
state such as the locomotor activity was also reported to affect the effect of MS optogenetic 
stimulation25. In this study, we characterized the stimulation effect by repeatedly testing 
the same parameters in a random fashion in an attempt to cancel out influence from 
behavioral states. Performing stimulation simultaneously with behavioral tasks or internal 
brain states measured by electrographic recording from MS may better clarify the potential 
participation of such states on hippocampal stimulation. 
2.4.5 Study Limitations 
 Although we have tested a large number of parameters, there is still a broad space 
which has not been explored, and it is unclear whether the results within our experimental 
parameter space will extrapolate to the broader space. Since frequency exhibited the 
highest optimizability in neural activity, it will be worth exploring a broader frequency 
range, within the biological limitations of the optogenetic channels. There is a possibility 
that a different predominantly modulated hippocampal neural feature (45Hz PSD in CA1 
and CA3) is observed if a different stimulation frequency range is applied.  
 In addition, the stimulation effect of MS GABAergic neurons was not identified as 
they were modulated together with some glutamatergic and cholinergic neurons when hSyn 
promoter was used. Such specific stimulation could be further explored with the use of 
transgenic animals. Selective modulation of GABAergic neurons may identify that the 
stimulation effect presented in hSyn-ChR2 animals is mainly induced by MS GABAergic 
neurons or by an interaction with the other neuronal subpopulations.  
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CHAPTER 3. DEVELOPMENT OF IN-VIVO OPTOGENETIC 
STIMULATION PARAMETER OPTIMIZATION 
3.1 Introduction 
Neuromodulation is becoming a fundamental tool for understanding and treating 
neurological and psychiatric diseases. The selection of parameters is of obvious critical 
importance for neuromodulation as many studies have shown that the modulation of neural 
feature activity and behavioral change is highly parameter dependent29. However, 
parameter selection has been done empirically and even sometimes arbitrarily in many of 
the preclinical studies and clinical trials26–28. Applying stimulation with the optimal 
parameters can improve the effectiveness of biomarker modulation. Moreover, optimal 
stimulation parameters are subject-specific, and further, the stimulation effect depends on 
the pre-stimulation neural state88–90 which implies that the optimal parameter is non-
stationary. Exhaustive parameter search methods such as a grid search or a random search 
require a tremendous amount of resource and time which also increases a chance of 
inducing a side effect. Therefore, the exhaustive search methods are especially not suitable 
for translational applications which usually demand a fast and safe algorithm. 
A Bayesian optimization (BaO), one of black box optimization algorithms, is a well-
developed field of engineering that can be applied to the problem of tuning stimulation 
parameters. The optimization algorithm requires two fundamental components–an 
objective function and a search space. The objective function is a quantitative measure of 
optimality, for example the value of an electrophysiological feature. The other component, 
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the search space, is the range of stimulation parameters that can be tested. This parameter 
space is typically constrained based on the capabilities of the stimulator, safety 
considerations, and the goal of the neural modulation intervention. Lorenz et al. 
demonstrated how BaO could search a parameterized space of audio-visual stimuli to 
identify the stimulus that maximizes the difference between temporal and occipital 
activation, as measured by fMRI91. Building on the findings from Lorenz et al., our work 
focused on using related black-box optimization approaches for tuning optogenetic 
stimulation of the medial septum (MS) based on its effect on hippocampal neural activity. 
In this chapter, I detail the validation and utility of BaO for MS optogenetic 
modulation of the hippocampal neural activity. The goal is to implement an autonomous 
system that learns a set of stimulation parameters that induce a desired hippocampal 
activity through iterative interaction with the neural circuit. Specifically, we tested this 
approach to modulate two different hippocampal neural activities in normal rats. The first 
test was to increase the low-gamma band power, which was identified as a hippocampal 
neural feature predominantly modulated by the MS optogenetic stimulation (Chapter 2). 
The second test was to increase the hippocampal theta band power. It was shown in the 
previous chapter that the theta power is only marginally or not increased with the tested 
stimulation parameters, so we expanded the parameter space to find the one which can 
effectively increase the theta power.   
3.2 Methods 
3.2.1 Animal preparation 
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 Two survival surgeries for virus injection (1st survival surgery), electrode 
implantation and optic ferrule/fiber implantation (2nd survival surgery) were conducted as 
described in 2.2.1. The experiment for this study was performed in total 6 rats. The 
parameter optimization for gamma power maximization and theta power maximization was 
performed in two and four rats respectively.  
3.2.2 Experimental setup 
 Electrophysiological recording was performed while a rat was awake and freely 
behaving. A headstage consisting of 16 recording channels with active impedance 
matching (Tucker Davis Technoolgies, TDT) was securely connected to the implanted 
electrode. A patch fiber cable (200μm diameter, 0.67 NA, Plexon) was used to connect to 
a 465nm blue LED to the implanted ferrule, which had been calibrated prior to the 
implantation. LFP were sampled at 25kHz and band-pass filtered at 1-200Hz (RZ2, TDT).  
3.2.3 Objective function calculation 
The hippocampal theta and gamma power were calculated by using MATALB 
Chronux toolbox with a multi-taper method. Recording channels which contained noise 
(e.g. motion artifact and 60Hz noise) excluded from the analysis.  
3.2.3.1 Hippocampal gamma power 
The absolute value of hippocampal low gamma (33-50Hz) power was used as an 
objective function during the optimization. 
3.2.3.2 Hippocampal theta power: expected theta modulation  
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The hippocampal theta power oscillates based on the behavioral or internal neural 
state of the rat, and a linear relationship was observed between the theta power in the 
current time window and the change of the theta power to the subsequent window (Figure 
8). We developed a new objective function, the expected theta modulation (ETM, Figure 
8) to incorporate this characteristic of the theta power. To calculate ETM, first, theta power 
was measured on ten overlapping 3s windows moving by 0.6 second during stimulation. A 
linear model was then used to estimate the relationship between theta power in one window 
as a predictor of the change in theta power to the next window. The triangular area under 
this line was then compared to a model generated from the previous baseline window. The 
difference in these areas was used to calculate the ETM. A positive ETM indicates that the 
corresponding stimulation parameter tends to increase theta power, while a negative ETM 
indicates the opposite. From an optimization perspective, the ETM is a scalarized approach 
to jointly maximizing the theta power in one time-window and the increase in theta power 
to the subsequent time-window.   
 
Figure 8. Introduction of theta power linear model (TLM) and expected theta 
modulation (ETM). A. A schematic of a moving window segmentation to generate 
TLM. Two consecutive 3-second segments were used for calculating theta (pre) and 
theta (on), and these windows moved 0.6 seconds each step. Ten pairs of theta (pre) 
and theta (on) were calculated for both baseline and stimulation period. B. Theta 
(pre) compromised a linear relationship with the differences between theta (on) and 
theta (pre). This linear relationship which is characterized by two factors (slope and 
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y-intercept) was dependent on the stimulation parameters. Three examples of the 
TLM, one with baseline and the other with two different stimulation parameter sets, 
are shown. C. Expected theta (ET) is defined by the area of the triangle formed by 
TLM and y=0 line. ETM is defined as the difference of ET between the baseline and 
the stimulation TLM.   
3.2.4 Bayesian closed-loop optimization 
BaO is a model-based optimization that has been used for optimization of expensive 
cost functions92. An overview of the BaO algorithm is shown in Figure 9. As the BaO 
algorithm queries the cost-function, it iteratively builds a model of the underlying data, 
which is then used to select which the area of the parameter space is to be subsequently 
sampled. Gaussian processes (GP) are typically employed as the underlying model, 
although other models such as random forests have been utilized. In our implementation, 
we used a GP with a constant mean function and a third order Matern kernel with automatic 
relevance detection for the covariance (Equation 7). 
 𝑘(𝑥𝑖, 𝑥𝑗|𝜃) = 𝜎𝑓
2(1 + √3𝑟)exp (−√3𝑟) 








The mechanism for selecting which point to sample is an acquisition function which 
can evaluate the improvement, or potential for improvement, of each point in the parameter 
space. While evaluating the objective function can be computationally expensive, the 
process of maximizing the acquisition function is comparatively cheap. In this analysis, we 
considered two acquisition functions:  




(𝜇(𝑥) − 𝑓(𝑥+) − 𝜉)Φ(𝑧) + 𝜎(𝑥)𝜙(𝑧) 𝑖𝑓 𝜎(𝑥) > 0
0 𝑖𝑓 𝜎(𝑥) = 0
 
𝑧 = {
(𝜇(𝑥) − 𝑓(𝑥+) − 𝜉)
𝜎(𝑥)
𝑖𝑓 𝜎(𝑥) > 0
0 𝑖𝑓 𝜎(𝑥) = 0
 
(8) 
Upper confidence bound (UCB): 
 𝐻𝑈𝐶𝐵 =  𝜇(𝑥) + √𝜅𝑡𝜎(𝑥) (9) 
where the sequence 𝜅𝑡 was defined as 𝜅𝑡 = 2log (𝑡
2𝜋2/6). 
 
Figure 9. Overview of the Bayesian optimization (BaO) algorithm. A) During an 
initial phase, sample points are randomly selected from a uniform distribution and 
evaluated. B) A Gaussian process model is then fit to the existing data. An 
acquisition function is then used to propose a candidate sample point based on the 
expectation and uncertainty estimated by the model. C) This proposed sample point 
is then evaluated, the model is updated with the new data, and the process B-C is 
repeated. 
3.2.5 Stimulation parameters  
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3.2.5.1 Parameters to maximize hippocampal gamma power 
Three parameters of a single-frequency pulse (Figure 10B) were optimized to 
maximize the hippocampal gamma power: an intensity of light (10-50I, 1I = 1mW/mm2), 
a frequency (5-42Hz) and a pulse-width (2-10ms).  
3.2.5.2 Parameters to maximize hippocampal theta power 
Two different stimulation parameter spaces were used and compared for 
optimization to maximize the hippocampal theta power. The first parameter space used a 
fixed intensity (30I or 50I) and pulse-width (8ms) but allowed for nested pulse-trains 
described by two frequency parameters (slow: 5-11Hz and fast: 35-100Hz, Figure 10A). 
This stimulation pattern consisted of high frequency pulses delivered in bursts at a lower 
frequency. The second parameter space was with a fixed intensity (30I or 50I, Figure 10B) 
single-frequency pulsatile square wave with parameters for pulse-width (1-8ms) and 
frequency (2-100Hz). 
 
Figure 10. Patterns of MS optogenetic stimulation. A. Nested pulse-train. B. 
Standard single-frequency pulse. 
3.2.6 In silico simulation 
3.2.6.1 Modeling the effect of medial septum optogenetic stimulation on hippocampal 
gamma power 
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Data from the previous chapter mapping medial septum optogenetic stimulation to 
hippocampal gamma power was collected from three subjects on three different 
experimental days for a total of 1267 samples. Subject-specific models mapping the 
stimulation parameters (intensity, frequency and amplitude) to the hippocampal gamma 
power were constructed by fitting the samples to a GP regression model that captures the 
expected hippocampal response to medial septum optogenetic stimulation. Therefore, this 
GP model can be used as a simulation platform by providing a hippocampal gamma power 
as an output when the stimulation parameter set was given as an input. The uncertainty of 
the output caused by adding noise to the output was also defined by the GP model.   
3.2.6.2 Simulation to compare random search and Bayesian optimization 
The efficiency of BaO to find the optimal stimulation parameter set to maximize 
the gamma power was compared to the random search method. The models mapping 
medial septum stimulation parameters to hippocampal gamma power as described above 
(3.2.6.1) were used to construct a simulation platform. Each simulation trial included 40 
samples for BaO and the random search, and the estimated optimal stimulation parameter 
set was found after every sample. BaO randomly explored the parameter space in first 10 
samples and then explored with the UCB acquisition function (Equation 9, mu =0.4) for 
the last 30 samples. The estimated optimal parameter set was decided by a GP model 
constructed with the tested samples and observations. Two different methods were used 
for random search to decide the estimated optimal parameter set: 1) the sample which 
observed the maximum gamma power and 2) the parameter set which supposedly 
maximizes the gamma power according to the GP model constructed with the tested 
samples and observations.  An error, a distance between ground truth and estimated 
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maximum gamma power, during the simulation exploring 40 samples was measured to 
evaluate each search method. The simulation was performed for three animals with 10 
repetitions for each animal.  
3.2.7 In vivo optimization 
3.2.7.1 Optimization to maximize hippocampal gamma power 
 Two subjects (R4 and R5) underwent the optimization and test cycle four times 
over the course of two weeks. During the optimization, each sample consisted of 20s of 
stimulation and were separated by 100s. Ten initial samples drawn from a uniform random 
distribution were used for the burn-in period, followed by 20 samples guided by the 
algorithm. The UCB acquisition function using a value of nu=0.4 (Equation 9) was used 
for the hyperparameter of the algorithm.  
3.2.7.2 Optimization to maximize hippocampal theta power 
Four male Sprague Dawley rats underwent the optimization and testing phases. 
Total of eight and seven trials were performed respectively for optimization of a standard 
single-frequency pulse and a nested pulse-train. For one of the subjects the optimization 
phase lasted for 50 samples, while for the other three, the optimization was stopped after 
30 samples or shorter if converged. 
During the optimization, each sample consisted of 11.4s of baseline and 8.4s of 
stimulation and were separated by 20s. The objective function, ETM, was calculated as 
described in Figure 8. Ten initial samples drawn from a uniform random distribution were 
used for the burn-in period, followed by 20 samples guided by the algorithm. The EI 
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acquisition function using a value of nu = 0.01 (Equation 8) was used for the 
hyperparameter of the algorithm. 
3.2.8 Post-optimization parameter test 
After finishing the learning phase of the optimization, no stimulation was delivered 
for 15 minutes. During the post-optimization testing phase, 30 stimulations were delivered 
– randomized between sham stimulation, the optimal stimulation parameters the algorithm 
identified as inducing the highest gamma or theta power, and the stimulation parameters 
identified as inducing a minimal change in hippocampal gamma or theta power (sub-
optimal). Each stimulation was applied for 5 seconds following 5 second baseline, and the 
50 second gap between two trials was placed to wash out the stimulation effect. 
3.3 Results 
3.3.1 Simulation to compare random search and Bayesian optimization 
The simulated results showed that BaO outperformed the random search for finding 
the optimal stimulation parameter set to maximize the hippocampal gamma power. The 
efficiency of BaO was compared with two random search methods, one without and 
another with the GP model to decide the estimated optimal parameter set as described in 
3.2.6.2. The trajectory of the error between the ground truth and the estimation of the 
maximum hippocampal gamma power was compared for each searching method (Figure 
11).  After 10th sample where the intelligent search begins for BaO, the error at each sample 
of BaO was lower than the one from the random search methods (Figure 11A). In addition, 
the final error at the end of search was significantly lower compared to the random search 
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(Figure 11B). These results demonstrated that BaO can find the optimal stimulation 
parameter set more quickly and accurately than the random search. 
 
 
Figure 11. Comparison between Bayesian optimization (BaO) and the random 
search for finding the optimal medial septum optogenetic stimulation parameter set 
to maximize the hippocampal gamma power. Random1 and Random2 represent the 
random search method to GP model (Random2) or not (Random1) for deciding the 
estimated optimal parameter set. A. The trajectory of the error. B. The final error 
at the end of the parameter search.  
3.3.2 Gamma power in vivo Bayesian optimization  
The optimal intensity and frequency of MS optogenetic stimulation to maximize 
the hippocampal gamma power were quickly found by the BaO algorithm. Figure 12 shows 
the trajectory of the parameters and the objective function (i.e. gamma power) during the 
initial random search and the intelligent search phase. At each sample, the estimated 
optimal stimulation parameters and the predicted hippocampal gamma are shown with 
solid lines. The actual stimulation parameters sampled are shown with dotted lines. In all 
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trials, the algorithm rapidly converged on intensity and frequency parameters within 10 
samples. The final estimated optimal parameter set was a combination of a high intensity 
and a high frequency. In contrast, the algorithm’s estimate of the pulse-width did not 
readily converge in all trials, and the final estimate of the optimal pulse-widths was more 
varied. The ‘lack’ of convergence and wide range of final values for pulse-width also 
agrees with the previous results showed the relative lack of influence of pulse-width on 
hippocampal neural activities above 2ms (Chapter 2, Figure 6).  
After the optimization phase and a short delay to allow for the washout of any 
potential accumulated effects, each subject underwent a prospective validation of the 
estimated optimal stimulation parameters. Overall, the estimated optimal parameters 
produced a hippocampal gamma power 2-2.5 times than during sham trials. The sub-
optimal stimulation parameters estimated to have the minimal effect on the objective 
function only marginally increase the gamma power. 
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Figure 12. A-C. Trajectory of optimization in vivo. Each subplot shows the traces for 
optimizing stimulation parameters (A-C) and gamma power (D) using the BaO 
algorithm to maximize the hippocampal gamma power. The solid line indicates the 
stimulation parameters (A-C) or the gamma power (D) that the optimization 
algorithm estimated to be optimal, while the dashed line shows the actual 
stimulation parameters sampled or the measured gamma power. E. The post-
optimization test results. Box plots show the normalized quartiles of the 
hippocampal gamma power using the optimal and sub-optimal subject-specific 
stimulation parameters along with the sham trials. Circles are the mean 
hippocampal gamma from each of the post-optimization test trials. The different 
colors correspond to different animals. 
3.3.3 Theta power in vivo Bayesian optimization 
3.3.3.1 Standard single-frequency stimulation 
Through both optimization and test phases, it was clear that standard pulsatile MS 
optogenetic stimulation was unable to induce a significant increase in hippocampal theta 
power. Figure 13A and B show the trajectories of the frequency and pulse-width sampled 
by the optimization algorithm (dotted line) and the estimate of the optimal (solid line) as 
additional samples are collected. The two example trials are shown in light vs. dark blue. 
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When searching for the frequency that maximizes the increase in hippocampal theta, we 
could see that the algorithm initially searched the range of parameters between 2 and 
100Hz. However, in one trial (light blue) after the first 10 random samples were collected, 
the algorithm immediately converged on 2Hz as the estimated optimal frequency, and only 
once sampled a different pulse-frequency at sample #33. In the second trial, the algorithm 
converged on a 2Hz pulse-frequency after sample #19 and similarly only sampled one other 
pulse-frequency, but without change the estimated optimal. For pulse-width, the two 
different trials converged on very different parameters: 1ms and 6.3ms, despite sampling 
the range of potential stimulation parameters during the burn-in phase (i.e. random search) 
and early in the optimization. This is likely due to the relative flatness of the objective 
function. In other words, changing the pulse-width of the stimulation has little impact on 
hippocampal theta power, so the algorithm selected parameters somewhat arbitrarily. 
Figure 13 shows the change in hippocampal theta power predicted by the model for the 
current estimate of the optimal stimulation frequency and pulse-width. For both trials, after 
the 10 burn-in samples were collected, the estimated change in hippocampal theta was 
negative (i.e. best stimulation decreases hippocampal theta). However, as the algorithm 
searched for the stimulation frequency and pulse-width that maximized hippocampal theta, 
it eventually found a set of parameters, specifically a pulse frequency of 2Hz, that 
minimally decreased the hippocampal theta. The validation results in Figure 13 show that 
this inability of single-frequency pulsatile MS optogenetic stimulation to increase 
hippocampal theta power above baseline is robust and generalizes across animals. In 
comparison to sham stimulation, the best set of stimulation parameters identified by the 
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optimization algorithm caused a slight, but not significant, decrease in hippocampal theta 
power. 
 
Figure 13. In vivo Bayesian optimization and testing of single-frequency pulsatile 
stimulation to increase the hippocampal theta power. A-B. Stimulation frequency 
and pulse-width, respectively, sampled by the optimization algorithm (dotted lines), 
along with estimate of the optimal stimulation parameters (solid line) as each new 
sample is collected. C. The predicted hippocampal theta power when the optimal 
stimulation parameters are applied according to the Gaussian process model. The 
light and dark blue traces indicate the two different trials from the same animal. D. 
Results of the testing phase. Each circle is the mean of 10 samples from either sham, 
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optimal, or suboptimal stimulation. The different colors correspond to different 
animals. 
3.3.3.2 Nested pulse-train stimulation 
Hippocampal theta power can be increased by applying MS optogenetic stimulation 
with nested pulse-train stimulation. With the finding that MS optogenetic stimulation using 
a standard single-frequency pulse could not provide our desired effect of increasing 
hippocampal theta power, we turned our focus to nested pulse-train stimulation (Figure 
10A). The optimization algorithm explored the two-dimensional space of possible 
parameters which consisted of the pulse-frequency and the train-frequency, while the 
intensity and pulse-width were fixed. The configuration of the BaO algorithm was the same 
as in the previous experiment searching the standard single-frequency parameter space. 
Figure 14 shows the results of using BaO to search the nested pulse-train parameter space 
to maximize hippocampal theta power. The trajectory for the two representative trials of 
optimization is shown in Figure 14A. We can see that for both trials, after the initial burn-
in phase, the algorithm rapidly converged on a pulse-frequency of 100Hz. While each trial 
sampled one other value, 35Hz, once, this did not change the estimated optimal stimulation 
parameter. In Figure 14B, we can see that for both trials the algorithm eventually converged 
on the lowest possible train-frequency (5Hz) as the estimated optimal. However, 
convergence to this parameter took longer in one trial than the other. In looking at the 
predicted effect of the current estimated optimal stimulation parameters, we can see that in 
both trials the optimization algorithm rapidly found stimulation parameters that could 
increase hippocampal theta above baseline. While in Figure 14B the trial in light blue 
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shows a late change in the estimated optimal train-frequency parameter, this did not have 
a substantial effect on the change in hippocampal theta power.  
 
Figure 14. In vivo Bayesian optimization and testing of nested pulse-train 
stimulation to increase hippocampal theta power. A-B. Stimulation pulse-frequency 
and train-frequency, respectively, sampled by the optimization algorithm (dotted 
lines), along with estimate of the optimal stimulation parameters (solid line) as each 
new sample is collected. C. The predicted hippocampal theta power when the 
optimal stimulation parameters are applied according to the Gaussian process 
model. The light and dark blue traces indicate the two different trials from the same 
animal. D. Results of the testing phase. Each circle is the mean of 10 samples from 
either sham, optimal, or suboptimal stimulation. The different colors correspond to 
different animals. 
When the estimated optimal parameters were compared with sham during the 
testing phase, it was clear that the BaO algorithm was able to identify a subset of the 
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parameter space that was able to induce an increase in hippocampal theta power above 
baseline (Figure 14D). Meanwhile, the sub-optimal parameters estimated to have the 
minimal effect on the objective function only marginally increase or decrease the theta 
power. 
3.4 Discussion 
Selecting neural modulation parameters and policies is a challenge that spans much 
of neuroscience, neurology, and neurosurgery. While evaluating any neurological 
intervention is time and resource intensive, the high dimensionality of stimulation 
parameters makes the problem of finding the optimal set difficult, if not intractable. The 
optimization framework presented here offers a principled approach to address this 
problem. As we have shown, BaO outperformed the random search method and can be 
directly applied in real-time to learn subject-specific optimal stimulation parameters. The 
simulation results showed that BaO can find the optimal parameter set than the random 
search. BaO was also able to find the optimal parameter set to maximize the hippocampal 
gamma power in the in vivo experiment. Moreover, with a suitable hypothesis, this 
algorithm can be used to search novel parameter spaces. We applied BaO to explore the 
parameter space of the novel nested-pulse train pattern and found the optimal stimulation 
parameter set to maximize the hippocampal theta power.  
The BaO algorithm confirmed that the effect of the standard pulsatile stimulation 
was limited to decreasing hippocampal theta power. Based on the previous study (Chapter 
2, Figure 7), it was likely that any of the stimulation parameters previously tested would 
decrease hippocampal theta power. However, it was possible that some unsampled 
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parameter combination in the parameter space would cause the desired increase in the 
hippocampal theta power. Using the BaO algorithm from the theta maximization 
experiments we were able to test this hypothesis. The closed-loop optimization approach 
was unable to find a set of stimulation parameters that increased hippocampal theta power, 
so it is verified again with a strong evidence that the standard pulsatile stimulation could 
only decrease the theta power. While the mechanism of why standard pulsatile stimulation 
of the MS could not increase hippocampal theta is beyond the scope of this study, one 
explanation is that stimulation at these lower frequencies entrains the hippocampal LFP to 
a very narrow frequency band while decreasing power in the adjacent bands. The net result 
is an overall decrease in power across the theta band.  
Black-box optimization can navigate novel parameter spaces when a suitable 
hypothesis is provided. While the space of standard pulsatile stimulation parameters was 
limited to decreasing hippocampal theta, we found that by switching to a space of nested 
pulse-train stimulation parameters we were able to successfully increase hippocampal theta 
power overall. The hypothesis that a nested pulse-train stimulation pattern could increase 
hippocampal theta power was loosely based on recent studies showing that electrical theta-
burst nested pulse-train stimulation of the MS/fornix could improve memory in epileptic 
rodents93. While we did not know a priori what the objective function mapping nested 
pulse-train parameters to hippocampal theta power, the BaO algorithm was able to find 
solutions that significantly increased theta power. This result demonstrated the ability of 
closed-loop optimization procedures to efficiently investigate unknown objective 
functions. 
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There are several factors that can prevent a successful optimization procedure. That 
nested pulse-train stimulation elicited the desired increase in hippocampal theta was the 
fortunate product of the specific selection of a parameter space with the correct 
controllability over the desired neural feature. Without these components the optimization 
procedure will not be successful regardless of the choice in optimization algorithm. 
Another critical factor is the correct engagement with the neural tissue and accurate 
measurement of the objective. One example of the former was shown in the optimization 
of nested pulse-train stimulation to increase the hippocampal theta. In one of the trials, the 
ability of MS optogenetic stimulation to modulate hippocampal theta power was 
substantially limited. This decrease occurred simultaneously, and was likely caused by, an 
inadvertent shift in the location of the fiber optic ferrule. With the light from the fiber optic 
no longer completely activating the channel rhodopsin in MS, and therefore modulating 
the hippocampus, it would be expected that the increase in hippocampal theta power is 
diminished. In sum, while closed-loop optimization can be a powerful tool, it is only as 
effective as the combination of parameter space, objective function, and engagement with 
the neural tissue. 
Closed-loop, black-box optimization has the potential to address a wide range of 
problems in neural modulation. While the framework presented here centered around 
optogenetic stimulation, which does not have an immediate direct pathway to clinical 
translation, there is no reason these algorithms cannot be extended to clinical therapy. 
Several extensions of the standard optimization algorithms may find specific application 
in the clinical domain. These include: multi-objective optimization where multiple neural 
features are mutually competitive and need to be addressed simultaneously, safe 
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optimization where regions of the parameter space may be unsafe but the location of these 
regions is unknown, and preferential optimization where the objective function is more 
subjective. Finally, there is state-dependent optimization, where the algorithm learns a 
stimulation policy that depends on the current stat of the neural system. Taken to its logical 
conclusion and combined with approaches from control theory, state-dependent 
optimization is a direct pathway to the application of optimal control theory to neural 
modulation. Ultimately, with the correct use of exploratory data and simulation models, 
black-box optimization approaches are well-poised to improve the process of tailoring 
neural modulation therapy to specific patients and therapy-dependent requirements. 
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CHAPTER 4. DEVELOPMENT OF DATA-DRIVEN MODELS TO 
DESCRIBE A PATHOPHYSIOLOGICAL HIPPOCAMPAL 
NEURAL STATE BASED ON ELECTROPHYSIOLOGICAL 
RECORDINGS IN THE EPILEPTIC RAT. 
4.1 Introduction 
Identifying therapeutically effective stimulation parameters for epilepsy requires a 
tremendous amount of time and resources as seizures can be infrequent and the space of 
possible stimulation parameters is vast. Data-driven models of seizure susceptibility can 
act as a surrogate for predicting how effective a set of stimulation parameters is. Using 
these models to guide a selection of the stimulation parameters can save time and resources 
for ultimately mitigating the seizures. 
There has been an effort to identify epileptic neural features from eletrophysiological 
recording. A few studies have shown that the epileptogenesis is presented in the neural 
activity in some animal epilepsy models. Bragin-et-al showed that high-frequency 
oscillations (HFOs) during the development of epilepsy was related to the appearance of 
spontaneous seizures in rat intrahippocampal kainic acid model32. Behr-et-al showed that 
a significant difference in a type of seizures as well as their onset zone between early stage 
and late stage in pilocarpine-treated rats94. A pattern of interictal spikes and HFOs was 
changed after rats experienced the first seizure in the same model33. In addition, Desai-et-
al showed that the peak of local field potential (LFP) in tetanus toxin (TeNT) epileptic rats 
was at the low-theta band while one in normal rats was at the mid-theta band30. A transition 
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in the wide power spectrum band of LFP was observed as the pathological symptom 
progressed in the same study. Activities in LFPs in the hippocampus and other brain 
regions right before the seizure onset (i.e. pre-ictal period) also have been explored. 
Sedigh-Sarvestani-et-al showed that hippocampal theta and delta power changed during 
the pre-ictal period31. Cadotte-et-al observed that the granger causality of LFPs between 
CA1 and dentate gyrus was changed prior to the seizure onset95. Additionally, the theta 
synchrony between dorsal hippocampus and medial prefrontal cortex increased during the 
pre-ictal period96. These studies suggest a further investigation to search neural features in 
a wider space and to characterize their activity during the progression of epileptogenesis 
and during the pre-ictal period.  
In this study, we developed data-driven models by characterizing epileptic neural 
features from electrophysiological recordings in the hippocampus. Two different data-
driven models were constructed to identify neural features and characterize their activities 
in a rat TeNT mesial temporal lobe epilepsy (MTLE) model.  One model was developed 
to track how a long-term seizure-susceptibility increases over time (epileptogenesis) in rats 
after the initial injection of TeNT. Another model was constructed to estimate a short-term 
likelihood of seizure onset (ictogenesis) in TeNT rats by classifying the hippocampal 
neural features extracted from pre-ictal and inter-ictal periods.  
4.2 Methods 
4.2.1 Tetanus toxin rat epilepsy model 
Tetanus neurotoxin injection into the hippocampus provides a rat model of MTLE 
in which the hippocampal circuit is primarily perturbed by disruption of GABAergic 
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neurotransmission97,98. It leads to chronic seizures characterized by high excitability 
without a large hippocampal cell loss or mossy fiber sprouting99. After a TeNT injection in 
the rat hippocampus, there are 10-14 days of the latent period without seizures followed by 
14-21 days of the active-seizure period (Figure 15). During the active-seizure period, the 
rat exhibits 0-6 behavioral or electrographical seizures per hour.  
 
Figure 15. A brief description of two periods observed in a rat tetanus toxin (TeNT) 
model. 
4.2.2 Animal preparation 
An adult male Sprague-Dawley rat underwent two surgical procedures as described 
in Laxpati-et-al 47. All procedures were approved by the Emory University Institute for 
Animal Care and Use Committee. The first survival surgery was an injection of a viral 
vector (AAV5-hSyn-hChR2(H134R), 1.8µL of 1013 particles/mL) to transfect the neurons 
in the medial septum (MS) as a part of another study. To the best of our knowledge, any 
effect of MS optogenetic virus in intrahippocampal TeNT model has not been reported. A 
second survival surgery was performed for the injection of TeNT and the implantation of 
the electrode into the hippocampus, and the implantation of the fiber optic ferrule into the 
MS. 10-45 ng of TeNT was injected into the dorsal hippocampus centered at 3.50mm 
posterior and 2.80mm lateral to bregma using a pulled glass pipette attached to an injector. 
Five 2.0mm stainless steel screws were mounted on the skull for the structural support and 
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to serve as the reference and ground for a multi electrode array (MEA). The 16-channel 
MEA (Tucker Davis Technologies, Alachua, FL), consisting of two rows of eight channels 
offset by 1mm, was advanced ventrally into the brain while single unit activity was 
observed from both the CA3 and CA1 regions of the hippocampus. After the MEA was 
placed in the desired location, the ferrule was driven into the MS. The craniotomy was 
sealed with dental acrylic to secure the electrode and the ferrule.  
4.2.3 Data collection 
The LFPs from the awake and freely behaving animals were recorded during the 
latent period and the active-seizure period (Figure 15). The LFPs were recorded from the 
hippocampus with 8 channels from CA1 and 8 channels from CA3. The data were collected 
by using TDT RZ2 acquisition system at 24414Hz and down-sampled to 2000Hz after DC-
filtered. Only baseline data which were recorded at least after 24-hour of stimulation were 
used for the entire study. The animals were monitored behaviorally and 
electrophysiologically every day to detect the 1st seizure. Both data from the latent and 
active-seizure periods were used for constructing epileptogenesis model, and the data from 
active-seizure period were used for constructing pre-ictal state model by characterizing 
LFP activities during the pre-ictal and inter-ictal periods. 
4.2.4 Epileptogenesis model construction 
4.2.4.1 Feature extraction 
Feature and Label: A feature set was calculated from the LFP recordings and 
labeled as a relative day to the first seizure (-7 to 18, Figure 15) to build a regression model. 
 66 
Calculation: A pool of educated frequency domain features was calculated by using 
MATLAB and Chronux toolbox. The feature pool consisted of 4 groups of 3-300Hz 
frequency domain features – power spectral density (PSD) in CA1 and CA3, coherence 
(COH) and phase coherence (PHASE) between CA1 and CA3. Two sets of PSDs were 
calculated and averaged from 8 channels in CA1 as well as 8 channels in CA3 respectively. 
COH and PHASE was calculated and averaged from 8 different pairs of facing channels, 
one from CA1 and another from CA3. To reflect that a frequency domain feature shows a 
similar pattern with nearby frequencies in the high frequency domain, 2Hz and 4Hz bins 
were used for 100-200Hz and 200-300Hz bands respectively while 1Hz bins were used for 
3-100Hz band. This binning method produced 172 features for each group (PSD CA1-
CA3, COH and PHASE) and 688 total features. Data having a seizure or a huge motion 
artifact were excluded from the feature calculation. Normalization: Normalization was 
performed by z-scoring the features from each animal separately. In each animal, values of 
a mean and a standard deviation (Std) of features were calculated from the latent and the 
active-seizure periods separately. Then by averaging the values from two periods, the final 
mean and Std values used for the z-scoring were calculated. Removing outliers was 
performed at the same time. Outliers of features such as one from an interictal spike 
accompanied a huge power, so their existence highly affected the calculation of mean and 
Std values as well as the normalization. Therefore, the outliers of features were excluded 
when calculating the mean and Std values. 
4.2.4.2 LARS-ENR 
 Least angle regression with elastic net regularization (LARS-ENR) is a linear fitting 
method which selects only a subset of features to avoid overfitting 68,100,101. It has an 
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advantage that the selected sparse feature set makes the model easily interpretable. The 
relationship between input (X) and output (y), and the solution to build a model are 
indicated by the following equations: 
 y=X×β + ε, 
β=arg min [║y - X×β║2 + delta×║β║2 + lambda×║β║] 
(10) 
The solution includes a linearly combined L1 and L2 penalties to avoid the 
overfitting. The LARS algorithm starts with an empty active feature set and iteratively 
calculates a new active feature set and adds a feature while following the direction of the 
model coefficients (β) toward the ordinary least square (OLS) solution. A new feature is 
collected when its correlation with the residual vector from the OLS is equally important 
with the active feature set. When a new feature is collected, a new direction toward the 
OLS with the current active feature set is calculated. The algorithm stops when the OLS is 
reached with the designated delta and lambda (Equation 10).   
4.2.4.3 Model building 
Epileptogenesis model (EGM) was built by repeatedly training, validating and 
testing a LARS-ENR model. 80% of the data was used for the training and validation of 
the model. To solve the unbalanced sample problem, we subsampled the positive-labeled 
(day>=0) samples to make its length same with the negative-labeled samples. We repeated 
the identical model construction process to fully exploit the positive-labeled samples while 
using the same set of negative-labeled samples for minimizing the information loss caused 
by the subsampling74. As LARS algorithm requires labels placed in the center, the negative 
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labels were multiplied by 2.285 to make the mean of the whole labels at 0. A nested cross 
validation was performed to find the best lambda and delta in the inner layer and to train 
and test the model in the outer layer. In the inner layer, 4-fold CV was performed within 
the training set only to select the best lambda and delta values which produced a minimum 
error. The selected lambda and delta were transferred to the outer layer to train the model 
with the whole training set. The 5-fold cross validation in the outer layer with 20 repetitions 
resulted in 100 different models. The final model was generated by averaging the 
coefficients of all trained models. The remained 20% of data were used for testing the final 
model. 
4.2.4.4 Feature analysis 
A subset of features informative to epileptogenesis was identified by leveraging a 
characteristic of ENR which removes unnecessary features. A feature was regarded as 
selected if it has a non-zero model coefficient. The coefficients of all trained models from 
CV and repetitions were investigated. A selected ratio of the features and the confidence 
interval based on binomial distribution were calculated. Features with the selected ratio 
greater than the chance were identified and grouped together with ones close. Activities of 
the grouped features were investigated, and those whose activity shows a certain pattern 
were identified as informative to epileptogenesis. 
4.2.5 Pre-ictal state model development 
4.2.5.1 Seizure detection 
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A seizure was defined by detecting a sum of wide band PSD (3-300Hz) above its 
baseline level (Figure 18A). A time series of the wide band PSD was calculated from 3 
second segments of the hippocampal LFP with the 1 second moving window. The 
thresholding value was calculated by the standard deviation of bottom 70% PSD values 
multiplied by 3, and a series of segments (>15 sec) with their PSD above the threshold was 
defined as a seizure.  
4.2.5.2 Feature extraction 
 The same set of frequency domain neural features as described in 4.2.4.1 were 
extracted from pre-ictal and inter-ictal periods. The pre-ictal period was defined as a 30-
second long window right before the seizure onset. Another long window (2-4 minute) 
placed at least 2-minute away from the end of the seizure and the per-ictal period was 
defined as the inter-ictal period. It was shown that the activity of the neural features was 
altered in both a daily basis as described by EGM (please see below section 4.3.1) and a 
minutely basis (i.e. transition between pre-ictal and inter-ictal). To describe only the 
transition between pre-ictal and inter-ictal states, the features were normalized by the 
baseline features extracted from the same day recording to offset the daily changes from 
epileptogenesis. These baseline features were extracted from LFPs during the inter-ictal 
period.  
4.2.5.3 SVM-ENR 
 Support vector machine with elastic net regularization (SVM-ENR) is a linear 
classifier which selects only a subset of features to avoid overfitting68,100,101. The 
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relationship between input (X) and output (y), and the solution to build a model are 
indicated by the following equations: 
 y=X×β + ε, 
β=arg min [║y - X×β║2 + lambda×║β║2  s.t. delta≥║β║] 
(11) 
The solution can be viewed as a linear regression with both L1 and L2 penalties to 
avoid the overfitting. The model coefficients (β) are decided with given regularization 
parameters (Equation 11, lambda and delta) 
4.2.5.4 Model building 
Pre-ictal state model (PiSM) was built by repeatedly training, validating and testing 
a SVM-ENR model which classifies neural feature samples from pre-ictal and inter-ictal 
periods. A 5-fold nested cross-validation was performed for training and testing the 
classifier.  In outer layer CV, 214 seizures were used for the training set and 53 seizures 
were used for the test set. By using separate groups of seizures for training and test sets, 
the overfitting and the generalizability between seizures were tested simultaneously. For 
the outer layer cross validation, 1284 and 8456 samples were extracted from the pre-ictal 
and inter-ictal period respectively. The samples from the inter-ictal period outnumbered 
the ones from the pre-ictal period which resulted in an unbalanced dataset for the 
classification. To address this issue, we divided the samples from the inter-ictal period to 
5 groups through a random selection so that each group has the equal number of samples 
with the pre-ictal samples. The classification was repeatedly performed for 5 different 
inter-ictal groups while using the same pre-ictal samples so that the loss of information 
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caused by subsampling is minimized74. During the training, the inner layer CVs were 
performed to optimize the hyperparameters (Equation 11, lambda and delta). Then the 
classifier was trained with the optimized hyperparameters in the outer layer and tested with 
the test set.    
4.2.5.5 Feature analysis 
As described above in 4.2.2.4, a subset of features which are informative to the pre-
ictal period was identified. Features of which selected ratio above the threshold were 
identified, and then the features close to each other were grouped together. An activity of 
the feature groups during the pre-ictal period was investigated, and those whose activity 
was altered during the pre-ictal period were identified as informative. 
4.3 Results 
4.3.1 Characterization of epileptogenesis  
4.3.1.1 Regression for progress of epileptogenesis 
EGM successfully described the progress of epileptogenesis in multiple rats with 
the frequency domain neural features.  A goodness of fit measured by R squared with the 
validation set during the cross validation was consistent (R2val = 0.724±0.025). The test set, 
which was never shown to the model, was used for purpose of testing the final model. The 
test set from day -7 to 18 was given to the final model, and the box plot in Figure 16 shows 
the output of the model. Overall, the model well predicted the relative day to the 1st seizure 
as the output of the model was well matched with their ground truth (Mean squared error 
(MSE)ovr = 23.1, R
2
ovr = 0.5090). The median of the output followed the y=x line until the 
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day 12th where it started to plateau. In the latent period, the model described the progress 
of epileptogenesis with a small output variance (MSElat = 3.16). Meanwhile, the output of 
the model varied more in the active-seizure period (MSEact = 23.9). 
 
Figure 16. The output of the epileptogenesis regression model (y-axis) with the test 
set (x-axis: ground truth). In both axes, the values indicate the relative day to Day 0 
(1st seizure day, negative: before & positive: after). A y=x line was superimposed to 
show the desired input output relationship.   
4.3.1.2 Informative neural features for epileptogenesis 
A few groups of neural features showed an increasing pattern during the pre-ictal 
period while others showed the opposite pattern (Figure 17). PSD of a low frequency band 
between 4-60Hz in CA1 gradually increased after the first day of seizure whereas a high 
frequency band between 70-200Hz in CA1 collapsed at day 0 and bounced back after few 
days. PSD of CA3 showed a similar pattern with CA1 PSD that a low-frequency band 
between 4-42Hz gradually increased while a high-frequency band between 230-270Hz 
decreased at Day 0 and bounced back. A theta band (3-11Hz) COH between CA1 and CA3 
showed a complex behavior that it gradually increased between day 0-6 and decreased after 
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day 6. The linear regression model, which is not available to describe the non-linearity, 
gave a positive coefficient for this feature group. The beta and low-gamma band (13-47Hz) 
COH showed a rapid increase after Day 0 and decreased below its latent-period value. 
Phase difference between CA1 and CA3 showed decrease in the beta (15-42Hz) and high-
frequency band (110-252Hz) after Day 0. The decrease of PHASE indicates that the phase 
of LFP in CA1 became smaller than the phase of LFP in CA3.  
 
Figure 17. Groups of neural features informative to epileptogenesis. A neural 
feature’s pattern of increase (blue) or decrease (red) during epileptogenesis is 
shown. 
4.3.2 Characterization of pre-ictal state 
4.3.2.1 Classification between pre-ictal and inter-ictal period 
The classification results show that differences exist in neural activities between 
pre-ictal and inter-ictal periods. The classifier, PiSM, was tested on the test dataset, and the 
classification results are plotted in Figure 18B which shows a receiver operation 
characteristic (ROC) curve with averaged area under curve (AUC, 0.7553) and the 
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classification accuracy (0.6875) indicated. Then a time series of neural features extracted 
from 300-second window before the seizure onset was streamed to the classifier. This 
generated a time series of the classifier output which indicates a likelihood of the seizure 
onset. The averaged classifier output at each timepoint relative to the seizure onset is 
plotted in Figure 18C. The classifier output gradually decreased from 120 second before 
the seizure onset and began to drop rapidly at 60 second before the onset. Then the test 
dataset was used for measuring the ratio classified as ‘pre-ictal’ at each timepoint (Figure 
18D). The ratio began to increase at 80 second before the seizure onset, and around 73% 
of test set was classified as ‘pre-ictal’ right before the seizure onset (193 of 253 test 
samples, each sample means one seizure). The averaged ratio classified as ‘pre-ictal’ was 
around 31% for the samples from inter-ictal period.  
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Figure 18. A. An example of hippocampal LFP during a seizure (top) and a seizure 
detection with the thresholding method (bottom). The seizure is detected and 
indicated by the red line. B.  ROC curve from the classification with the test set. C. 
Time series of pre-ictal state model (PiSM) output with the confidence interval 
(shaded area). The average value of the PiSM output during inter-ictal period is 
indicated by the red line. D. The ratio of classified as pre-ictal for each time point. 
The average ratio during the inter-ictal period is indicated by a red line.   
4.3.2.2 Informative neural features for pre-ictal state 
A few groups of neural features showed an increasing pattern during the pre-ictal 
period while others showed the opposite pattern (Figure 19). A high frequency band PSD 
between 260-280Hz in CA1 slightly increased during the pre-ictal period. COH between 
CA1 and CA3 in beta band (25-39Hz) and a high frequency (182Hz) as well as PHASE in 
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172-174Hz increased during the pre-ictal period. In contrast, low frequency band power in 
CA1 (4-21Hz) and CA3 (3, 21-33Hz) decreased during the pre-ictal period. Also, low 
frequency COH (3-7Hz) and phase difference in 53Hz between CA1 and CA3 decreased. 
Low frequency PSD and COH began to decrease earlier than the other features (~70 
seconds before seizure onset). Other features, especially those which increased, started to 
be altered closer to the seizure onset.  
 
Figure 19. Groups of neural features informative to pre-ictal state. A neural 
feature’s pattern of increase (blue) or decrease (red) during the pre-ictal period is 
shown.  
4.3.3 Hippocampal theta power 
It has been repeatedly reported that the hippocampal theta band (4-10Hz) power is 
related to the epilepsy and seizures, and the theta power was identified as an informative 
neural feature to a neural state transition during epileptogenesis and the pre-ictal period in 
our study. In EGM, the theta power showed a pro-seizure characteristic as its level was 
higher during the active-seizure period than the latent period (Figure 20A). However in 
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PiSM, the theta power showed an anti-seizure characteristic as it gradually decreased 
during the pre-ictal period (Figure 20B).   
 
Figure 20. The hippocampal theta power (4-10Hz) during epileptogenesis (A) and 
the pre-ictal period (B). A. The theta power trace before and after the first seizure 
day (Day 0) with the confidence interval (shaded area). B. The theta power trace 
before the seizure onset (Time 0) with the confidence interval (shaded area). The 
averaged theta power during the inter-ictal period is indicated by the black line. 
4.4 Discussion  
The data-driven models were constructed to describe neural states during the 
progress of epileptogenesis and the pre-ictal period in TeNT rats. In addition, by using a 
feature reduction technique we identified informative neural features. First, EGM which is 
a linear regression model was able to predict a day relative to the first seizure. The output 
of EGM during the active-seizure period was clearly different from the active-seizure 
period, so a long-term susceptibility of seizures can be inferred by the model output. 
Second, PiSM was able to detect the different behaviors of neural features during the pre-
ictal period compared to the inter-ictal period. Therefore, the output of PiSM indicates a 
short-term seizure susceptibility.  
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The output of the models can play a surrogate role in investigating the stimulation 
effect for developing the seizure treatment with neuromodulation. Finding the effective 
stimulation parameters is the key part of optimizing the treatment. However, it requires a 
huge amount of time and resources to explore the vast parameter space. Examining the 
effect on the surrogate instead of the epileptic symptom can save a tremendous amount of 
time to find effective stimulation parameters. The models were constructed to estimate a 
susceptibility of seizures, so modulating the model output is expected to change the neural 
state of the seizure susceptibility. A causality test is required to test if modulating the model 
output is causal to the epileptic symptom change. The data-driven model can be used for 
epilepsy treatment only when the causality exists.  
A contradictory relationship between the hippocampal theta power and the seizure 
susceptibility encourages to examine the effect of the theta power modulation via external 
brain stimulation. In previous studies, Sedigh-Sarvestani-et-al31 reported an anti-seizure 
characteristic of the theta power whereas the opposite was observed by Colom-et-al102 and 
Desai-et-al30. Our results agreed with the literatures by showing both anti- and pro-seizure 
characteristics of hippocampal theta power (Figure 20). The theta power showed a pro-
seizure characteristic in EGM whereas it showed the opposite characteristic in PiSM. 
Testing the effect of artificially increased theta power via external brain stimulation on 
seizure can validate the use of the theta power as a surrogate as well as can provide a better 
understanding of the theta power in epilepsy.  
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CHAPTER 5. MODULATION OF HIPPOCAMPAL EPILEPTIC 
NEURAL STATES VIA MEDIAL SEPTUM OPTOGENETIC 
STIMULATION 
5.1 Introduction 
 Stimulation parameters which successfully suppressed seizures in both human 
epilepsy patients and animal models of epilepsy were not consistent, were rather various 
according to the previous studies. In human patients, both 130Hz biphasic pulses of 
electrical stimulation in the hippocampus103 and much slower 5Hz bipolar electrical 
stimulation in the fornix104 suppressed seizures. An optogenetic stimulation with constant 
light in the hippocampal GABAergic neurons105 and 130Hz light in the dentate gyrus 
GABAergic neurons106 suppressed seizures in the rodent kainic acid model. These results 
suggest that there does not exist one ideal stimulation parameter for the seizure suppression 
but potentially depends on the stimulation target, subject-specific anatomical or 
pathological characteristic and so on.  
 A selection of stimulation parameters is important to improve the stimulation 
effectiveness for epilepsy treatment as different parameters can induce different effects. 
However, testing a set of stimulation parameters requires a lot of time and resources. An 
effective stimulation parameter set found in one subject may not be generalizable across 
the subjects due to the variability of the stimulation effect between subjects107–109. 
Moreover, a natural or pathological neural state transition can yield a change of stimulation 
effect within the same subject110–112. In the previous chapter, we constructed data-driven 
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models which can be used as a surrogate of the epileptic symptom. Looking at the effect 
of stimulation on the surrogates rather than the epileptic symptom can save time and 
resources. However, the parameter space is still vast to find the optimal set in a short time.  
 In this chapter, I developed an effective way to modulate a neural feature or neural 
state model by applying the optimization platform introduced in chapter 3. A few 
modifications were required for applying the optimization for epileptic rats as they show 
frequent ictal discharges which hides the effect of the stimulation. In the first experiment, 
the medial septum (MS) optogenetic stimulation parameters for increasing the 
hippocampal theta power was optimized. Second, MS optogenetic stimulation parameter 
was optimized for effectively inducing the anti-seizure state by regulating the output of the 
pre-ictal state model (PiSM, Chapter 5). The subject-specific optimal stimulation 
parameter found by the optimizer can improve the effectiveness of the stimulation by 
solving an issue of variability in stimulation effects between subjects. 
5.2 Methods 
5.2.1 Animal preparation 
An adult male Sprague-Dawley rat underwent two surgical procedures as described 
in Laxpati-et-al47. All procedures were approved by the Emory University Institute for 
Animal Care and Use Committee. The first survival surgery was an injection of a viral 
vector (AAV5-hSyn-hChR2(H134R), 1.8µL of 1013 particles/mL) to transfect the neurons 
in MS. A second survival surgery was performed for the injection of TeNT and the 
implantation of the electrode into the hippocampus, and the implantation of the fiber optic 
ferrule into the MS. 10-15 ng of TeNT was injected into the dorsal hippocampus centered 
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at 3.50mm posterior and 2.80mm lateral to bregma using a pulled glass pipette attached to 
an injector. Five 2.0mm stainless steel screws were mounted on the skull for the structural 
support and to serve as the reference and ground for a multi electrode array (MEA). The 
16-channel MEA (Tucker Davis Technologies, Alachua, FL), consisting of two rows of 
eight channels offset by 1mm, was advanced ventrally into the brain while single unit 
activity was observed from both the CA3 and CA1 regions of the hippocampus. After the 
MEA was placed in the desired location, the ferrule was driven into the MS. The 
craniotomy was sealed with dental acrylic to secure the electrode and the ferrule.  
5.2.2 Inter-ictal spikes removal 
 A removal of inter-ictal spikes was required for measuring the stimulation effect on 
neural features in epileptic animals. Inter-ictal spikes (IISs) accompany a high amplitude 
local field potential (LFP) which affects a wide frequency band of power spectral density 
(PSD) and coherence. This can hinder identifying the effect of stimulation on the frequency 
domain neural features. IISs in LFPs were removed by thresholding the wide band PSD (1-
30Hz). A sum of the PSD (1-30Hz) was calculated in 16-channel LFP by using a sliding 
window (0.5 second width and 0.1 second resolution), and a threshold value for each 
channel was decided as the following equation: 
 𝑇ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑 =  75% 𝑝𝑒𝑟𝑐𝑒𝑛𝑡𝑖𝑙𝑒 + 1.5 × (75% 𝑝𝑒𝑟𝑐𝑒𝑛𝑡𝑖𝑙𝑒
− 25% 𝑝𝑒𝑟𝑐𝑒𝑛𝑡𝑖𝑙𝑒) 
(12) 
 Short LFP segments of which 1-30Hz PSD was above the threshold were classified 
as IIS. An example of IIS detection is shown in Figure 21. LFPs and their PSD during the 
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baseline (black) and the MS optogenetic stimulation (Figure 21 blue, nested pulse-train: 
50I-5.2Hz-67.8Hz) are shown for before and after IIS removal. A huge power throughout 
the wide frequency band due to IIS was suppressed and the effect of the stimulation, peaks 
around 21, 30 and 67.8Hz in PSD, emerged after removing IISs. 
 
Figure 21. Inter-ictal spikes (IISs) removal. A-B. Hippocampal LFPs during the 
baseline (black) and stimulation (blue) before (A) and after (B) IISs were removed. 
C-D. PSD of the corresponding LFPs before (C) and after (D) IIS removal. 
5.2.3 In vivo optimization for theta power 
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 The optimal MS optogenetic stimulation parameter set for increasing the theta 
power was found by leveraging Bayesian optimization (BaO) when the rats were freely 
behaving. The in vivo BaO algorithm was implemented with Gaussian process (GP) model 
and UCB acquisition function (nu = 0.4, Equation 9) as described in Chapter 3. Two 
parameters of nested pulse-train (Figure 10A), a train-frequency and a pulse-frequency 
were optimized while an intensity (50I, 1I = 1mW/mm2), a pulse-width (4ms) and a train-
width (75ms) were fixed. Each optimization sample for testing a stimulation parameter set 
consists of 8 second baseline and 8 second stimulation. The theta power was calculated 
after inter-ictal spikes were removed from LFPs. If remained LFP after IIS removal was 
shorter than 3 second, the corresponding sample was abandoned and repeated. Then the 
objective function, the theta power change between baseline and the stimulation, was 
calculated and used for updating the GP model.  The parameter space was explored with 
the random search for the first 10 samples, and then the intelligent search followed for next 
30 samples. During the intelligent search, a next sample of the stimulation parameter set 
was selected by the acquisition function (UCB, Equation 9).  Optimization was finished 
after the 40th sample, and the optimal parameter set was identified according to the GP 
model.  
5.2.4 In vivo optimization for pre-ictal state model 
 The optimal stimulation parameter set for inducing anti-seizure neural state was 
found by leveraging BaO when the rats were freely behaving. The goal of the optimization 
was to increase the output of PiSM (PiSM score) where a high score indicates a neural state 
of less seizure likelihood (Chapter 4, Figure 18). The same optimization configuration with 
the theta power optimization was used. To reflect the natural oscillation of the PiSM score, 
 84 
a new form of the objective function was designed. A baseline pattern of the PiSM score 
showed that the scores from two consecutive time window were negatively correlated 
(Figure 22A). Therefore, the PiSM score change between two windows was larger when 
the pre-stimulation score was negative and the score change was smaller when the pre-
stimulation score was positive (Figure 22B). The state-dependency of the PiSM score can 
confuse the optimization process as it cannot distinguish between the stimulation effect 
and the natural oscillation. To solve this issue, the following equation (Equation 13) was 
used for calculating the objective function which can incorporate both pre-stimulation state 
and the stimulation effect. Two values were multiplied where the first one indicates the 
pre-stimulation score and the second one indicates the score change induced by the 
stimulation effect and the natural state oscillation. Both values were added by 1 to make 
them positive.  
 𝑂𝑏𝑗𝑒𝑐𝑡𝑖𝑣𝑒 𝐹𝑢𝑛𝑐𝑡𝑖𝑜𝑛
= (1 + 𝑃𝑖𝑆𝑀 𝑠𝑐𝑜𝑟𝑒1) × (1 + 𝑃𝑖𝑆𝑀 𝑠𝑐𝑜𝑟𝑒 𝑐ℎ𝑎𝑛𝑔𝑒) (13) 
 The objective function was calculated and used for updating the GP model. The 
first 10 samples were for the random search, and then the intelligent search was performed 
for next 30 samples. During the intelligent search, a next sample of stimulation parameter 
set was selected by the acquisition function (UCB, Equation 9). Optimization was finished 




Figure 22. A natural oscillation of PiSM score. A. PiSM scores from two consecutive 
8 second windows showed a negative relationship (Blue: score1 < 0 and red: score1 
≥ 0). B.  A comparison of score2 between negative (blue) and positive (red) score1. 
5.3 Results 
5.3.1 Maximization of theta power 
 The optimal parameter set for increasing the theta power was found by testing 40 
parameter sets through BaO. The series of the objective function, the theta power change, 
shows that the parameter sets tested during the intelligent search (11th-40th) induced a large 
theta power increase than the parameter sets tested during the random search (1st-10th, 
Figure 23A). An example of GP model shows that the effectiveness of the stimulation for 
increasing the theta power depends on selecting a right combination of a train-frequency 
and a pulse-frequency (Figure 23B). The optimal parameter was verified by comparing its 
effectiveness to sham and a sub-optimal parameter set. The parameter set which induced a 
zero or closest to zero theta power change was selected as the sub-optimal parameter set. 
Five different animals were tested, and each animal underwent 40 different trials for each 
parameter set (i.e. sham, optimal or sub-optimal). The optimal stimulation parameter set 
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induced the largest change (35.2% increase in average) from the baseline theta power 
(Figure 23C). Also, the level of theta power was highest when the optimal stimulation 
parameter set was applied compared to the sham or the sub-optimal parameter set (Figure 
23D).  
 
Figure 23. Stimulation parameter optimization for hippocampal theta power 
maximization. A. Theta power change for each sample (1st-10th: random search and 
11th-40th: intelligent search). B. An example of GP model at the end of the 
optimization. The optimal parameters for 5 different animals are superimposed. C-
D. A comparison of the theta power change (C) and the theta power (D) induced by 
sham, optimal and sub-optimal parameters in 5 different animals. Every dot and 
error bar represent a mean and the confidence interval of 40 trials. 
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5.3.2 Induction of anti-seizure neural state 
 The optimal parameter set for inducing the anti-seizure neural state is the one 
maximizes the PiSM score, and it was found by testing 40 parameter sets through BaO. 
The series of the objective function shows that the parameter sets tested during the 
intelligent search (11th-40th) induced a large PiSM score increase than the parameter sets 
tested during the random search (1st-10th, Figure 24A). An example of GP model shows 
that the effectiveness of stimulation for increasing the objective function depends on 
selecting a right combination of a frequency-train and a frequency-pulse (Figure 24B). The 
optimal parameter set was verified by comparing its effectiveness to sham and a sub-
optimal parameter set. The parameter set which minimized the objective function 
(Equation 13) was selected as the sub-optimal parameter set. The optimization experiment 
was performed in five different animals, and two animals were tested in two days while the 
others were tested once. After optimization, the animal underwent 40 different trials for 
each parameter set (i.e. sham, optimal or sub-optimal). The optimal set induced the largest 
score increase (Figure 24C) and the highest score level (Figure 24D).  In 3 different 
animals, the optimal stimulation parameter set increased the PiSM score. The optimal set 
increased PiSM score more than sham in 4 animals and than the sub-optimal sets in 3 




Figure 24. Stimulation parameter optimization for increasing PiSM score. A. 
Objective function described in Equation 13 for each sample (1st-10th: random 
search and 11th-40th: intelligent search). B. An example of GP model at the end of 
the optimization. The optimal parameters for 5 different animals (7 trials) are 
superimposed. C-D. A comparison of the PiSM score change (C) and the PiSM score 
level (D) induced by sham, optimal and sub-optimal parameters in 5 different 
animals. Every dot and error bar represent a mean and the confidence interval of 80 
trials (green and black, 40 trials each for two different days) or 40 trials (others, one 
day). 
5.3.3 State dependency of stimulation effect 
 The effectiveness of the optimal stimulation parameters for increasing the 
hippocampal theta power or the PiSM score depended on the pre-stimulation state (Figure 
25). The theta power increase induced by sham, the optimal or the sub-optimal parameter 
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sets was compared between a high-theta and a low-theta pre-stimulation state (Figure 25A). 
The pre-stimulation theta power above its median was defined as a high-theta state and the 
one below its median was defined as a low-theta state. The amount of the increased theta 
power induced by the optimal stimulation parameter was much lower when the pre-
stimulation power was high. The theta power decreased with sham or sub-optimal 
parameters when the pre-stimulation power was high. Similarly, the PiSM score increase 
induced by sham, the optimal or the sub-optimal parameter sets was compared between a 
high-PiSM and a low-PiSM pre-stimulation state (Figure 25B). The positive pre-
stimulation PiSM score was defined as a high-PiSM state, and the negative one was defined 
as a low-PiSM state. The optimal stimulation parameters were able to increase the PiSM 
score when the pre-stimulation score was low but only maintained the score when the pre-
stimulation score was high. Therefore, the optimal stimulation induced a transition from 
the pro-seizure state to the anti-seizure state and maintained the anti-seizure neural state. 
The sub-optimal parameters did not effectively increase or maintain the PiSM score than 
sham which showed the natural oscillation of the PiSM score.  
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Figure 25. A state-dependency of the stimulation effect. The normalized change of 
the hippocampal theta power and the PiSM score was compared between a low and 
high pre-stimulation state. A. The theta power change when the pre-stimulation 
theta power was above (left) or below (right) the median.  B. The PiSM score change 
when the pre-stimulation score was above (left) or below (right) zero. 
5.4 Discussion 
 The in vivo BaO platform was modified to become suitable for epileptic animals 
where abnormal neural activities such as inter-ictal spikes emerge frequently. The modified 
BaO was applied to find the optimal MS optogenetic parameters which can effectively 
increase the theta power or induce anti-seizure neural state by increasing the PiSM score.  
 A variability in the stimulation effect was observed for both between subjects and 
within a subject. The variability between subjects was presented in two forms. First, the 
optimal parameter sets found by the optimization were spread across the entire parameter 
space (Figure 23B and Figure 24B). Second, the effectiveness of the optimal parameter 
sets was not consistent. The amount of increase in the theta power or the PiSM score 
induced by the optimal parameters was various across the animal (Figure 23C-D and Figure 
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24C-D).  A high variability in the stimulation effect within a subject was observed during 
the multiple trials in the same day. Varying stimulation effects were observed when the 
identical stimulation parameter set (i.e. optimal or sub-optimal) was applied as indicated 
by the high confidence intervals of the theta power and the PiSM score modulation (Figure 
23C-D and Figure 24C-D).  
 The high variability may originate from the state-dependency of the stimulation 
effect. The identical stimulation parameter set induced different effects depending on the 
pre-stimulation states (Figure 25). In addition, the state-dependency of the stimulation 
effect can potentially explain the low effectiveness of the optimal parameters observed in 
few subjects. The sub-optimal parameters were more effective for increasing the PiSM 
score than the optimal parameters in two animals when the pre-stimulation score was low 
(Figure 25, blue and black). This implies that the effective parameter set needs to be 
searched again if a state transition occurs. 
 The state-dependent Bayesian optimization (SDBaO) which incorporates the pre-
stimulation state can improve the effectiveness of the stimulation. The SDBaO 
outperformed the standard Bayesian optimization by learning a state-dependent policy 
which selects the optimal stimulation parameters based on the pre-stimulation state 
(Connolly-et-al, in press). The modulation of the theta power and the PiSM score can be 
improved by applying the SDBaO. The variability in the stimulation effect and its state-
dependency are already proven, and thus incorporating the pre-stimulation state will 
improve the stimulation effectiveness.  
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CHAPTER 6. VALIDATION OF DATA-DRIVEN APPROACH BY 
IDENTIFYING CAUSAL LINK BETWEEN MODULATION OF 
HIPPOCAMPAL NEURAL STATES AND SEIZURE 
CHARACTERISTICS 
6.1 Introduction 
Finding the effective stimulation parameters is the key part of optimizing the 
treatment113–115. It requires a large amount of time and resources to explore the vast 
parameter space. Examining the effect on the surrogates instead of directly on epileptic 
symptoms can save tremendous time to find effective stimulation parameters. In previous 
chapters, the data-driven model was constructed to describe a susceptibility of seizures. 
The optimization tool was demonstrated that it can find effective stimulation parameters to 
modulate a neural feature or the output of the data-driven model. The last step of the data-
driven surrogate approach is to validate the surrogate neural state models by testing a causal 
relationship between epileptic symptom and the modulation of surrogates.  
A few studies have shown that the modulation of neural features can affect the 
behavioral output or pathological symptoms23,24,116. Hultman-et-al constructed a neural 
state model and showed that an injection of chemical agent changed both output of the 
neural state model and the depression symptom116. Fuhrmann-et-al showed that modulation 
of the peak frequency in the hippocampal theta band power by delivering the MS 
optogenetic stimulation can control the locomotion speed24. Gangadharan-et-al also 
showed that the hippocampal theta power externally modulated via optogenetic stimulation 
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was correlated with a performance of exploration23. However, it still needs to be done to 
improve the efficacy of behavioral or pathological intervention by optimizing the 
stimulation parameters or finding more appropriate neural features in the wider space.  
In this study, we tested and compared various stimulation strategies to find the 
optimal one as well as to investigate the causal relationship between neural feature 
modulation and the epileptic symptom (i.e. seizure). We tested three stimulation strategies 
including one conventional approach and two surrogate approaches. The conventional 
approach applied stimulation parameters selected empirically. The first surrogate approach 
applied the optimal parameter set to increase the hippocampal theta power, a well-known 
epileptic neural feature30,31,102, and the second surrogate approach applied the optimal 
parameter set to induce an anti-seizure neural state. To induce the anti-seizure neural state, 
a susceptibility of seizures was inferred by the output of pre-ictal state model (PiSM) 
described in Chapter 4. The optimization for finding effective parameters was performed 
as described in Chapter 5. The therapeutic efficacy of these strategies was compared with 
the sham trials, and the optimal parameters to increase the theta power was most effective 
to suppress seizures.  
6.2 Methods 
6.2.1 Animal preparation 
An adult male Sprague-Dawley rat underwent two surgical procedures as described 
in Laxpati-et-al [6]. All procedures were approved by the Emory University Institute for 
Animal Care and Use Committee. The first survival surgery was an injection of a viral 
vector (AAV5-hSyn-hChR2(H134R), 1.8µL of 1013 particles/mL) to transfect the neurons 
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in the medial septum (MS) as a part of another study. A second survival surgery was 
performed for the injection of TeNT and the implantation of the electrode into the 
hippocampus, and the implantation of the fiber optic ferrule into the MS. 10-15 ng of TeNT 
was injected into the dorsal hippocampus centered at 3.50mm posterior and 2.80mm lateral 
to bregma using a pulled glass pipette attached to an injector. Five 2.0mm stainless steel 
screws were mounted on the skull for the structural support and to serve as the reference 
and ground for a multi electrode array (MEA). The 16-channel MEA (Tucker Davis 
Technologies, Alachua, FL), consisting of two rows of eight channels offset by 1mm, was 
advanced ventrally into the brain while single unit activity was observed from both the 
CA3 and CA1 regions of the hippocampus. After the MEA was placed in the desired 
location, the ferrule was driven into the MS. The craniotomy was sealed with dental acrylic 
to secure the electrode and the ferrule. 
6.2.2 Overview of causality test 
Three different stimulation strategies were tested and compared with sham 
stimulation to evaluate the therapeutic effectiveness of the data-driven surrogate approach 
and the conventional approach. (1) 7Hz stimulation (Intensity: 50I, 1I = 1mW/mm2, 
frequency: 7Hz and pulse-width: 10ms): the first stimulation strategy, as a part of the 
conventional approach, applied the stimulation parameter empirically selected based on the 
previous study that 7Hz pulsatile electrical stimulation in the hippocampus suppressed the 
seizures30. The data-driven surrogate approach was used for developing the second and 
third stimulation strategies. (2) Theta stimulation: the second strategy applied the optimal 
stimulation parameters to increase the hippocampal theta power which showed the anti-
seizure characteristic during the pre-ictal period (Chapter 4). (3) PiSM stimulation: the 
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third strategy applied the optimal stimulation parameters to increase the output of pre-ictal 
state model (PiSM score) of which high score indicates the estimated anti-seizure neural 
state. (4) Sham stimulation: sham stimulation was performed by not applying the 
stimulation while keeping the other experimental setup the same. Each strategy was tested 
once in 5 different rats with a randomized order. Only one test was conducted per day, and 
the beginning time of the experiment was consistent to not be affected by the circadian 
rhythm. 
A timeline for the experiment is shown in Figure 26. After a rat was connected to 
the headstage and the patch cable, the rat was given 15 minutes to habituate to the 
experimental space. Then the baseline recording was conducted for one hour. Next, in vivo 
optimization was performed to find the optimal parameter for theta power maximization or 
PiSM score regulation. Two strategies (Sham and 7Hz) did not require the optimization as 
their stimulation parameters were already decided (7Hz or no stimulation), but the 
optimization was still performed to control the potential residual stimulation effect during 
the optimization. A brief period (10 minutes) was given to washout the stimulation effect 
during the optimization. Then, the stimulation with 7Hz or the optimal parameter set was 
applied for one hour continuously. Lastly, one-hour recording was performed to test the 
post-stimulation effect.  
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Figure 26. Experimental diagram for causality test. The seizures were detected for 
three phases – baseline, stimulation and post-stimulation. 
6.2.3 In vivo optimization 
In vivo Bayesian optimization described in Chapter 5 was performed to find the 
optimal parameters for the surrogate approaches. Two frequencies, a train-frequency and a 
pulse-frequency were optimized to effectively increase the hippocampal theta power or the 
PiSM score. The intensity (50I, 1I = 1mW/mm2) and the pulse-widths (Train: 75ms and 
pulse: 4ms) were fixed. 
6.2.4 Seizure detection and quantification 
The seizures were detected with the low-frequency (3-300Hz) power thresholding 
method as described in Chapter 4. A time series of the wide band PSD was calculated from 
3 second segments of the hippocampal LFP with the 1 second moving window. The 
thresholding value was calculated by the standard deviation of bottom 70% PSD values 
multiplied by 3, and a series of segments (>20 sec) with their PSD above the threshold was 
defined as a seizure (Figure 18A, Chapter 4). The video was used to confirm seizures to 
avoid false detection.  After seizures were detected, the number of seizures and the total 
time of seizures were measured. If a seizure was trimmed due to the seizure onset or 
termination outside of the experimental window, it was counted as one seizure but the time 
spent only during the experiment was measured as a seizure length. If a seizure length is 
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not clearly measurable due to a disconnection between the headstage and the electrodes, 
the corresponding trial was not included for the analysis of the total time of seizures 
(indicated as * in Table 1-8).  
6.2.5 Statistical test 
A seizure frequency and total seizure time were calculated and used to find 
stimulation effects and compare the stimulation strategies. First, a paired t-test was 
conducted to investigate the stimulation effect during the stimulation and post-stimulation 
phases. Then, a three-way ANOVA with the model including the two-factor interactions 
was conducted to test the effects of multiple factors (i.e. experimental phase, stimulation 
strategies and animals). Lastly, Tukey’s honest significant difference (HSD) criterion post 
hoc test was conducted to calculate adjusted p-values by reflecting the multiple 
comparisons. These three tests were performed again for the normalized seizure frequency 
and the normalized total seizure time. The seizure frequency and the seizure total time 
during the stimulation and post-stimulation phases were normalized to the one from the 
baseline phase (Equation 14, S is a seizure frequency or total seizure time). All statistical 







6.3.1 Seizure frequency 
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The number of seizures per hour (i.e. seizure frequency) was measured during baseline, 
stimulation and the post-stimulation phases to compare the effectiveness of the stimulation 
strategies (Table 2-Table 5). The P-values from the statistical analyses are shown in Table 
6 and Table 7. The 3-way ANOVA test for the raw seizure frequency and the normalized 
seizure frequency showed that the stimulation strategy and the animal subject had effects 
on the seizure frequency (Table 6, α=0.05). The results of ANOVA can be interpreted as 
that each stimulation strategy induced different effects on the seizure frequency and the 
variability between subjects made the animal one of significant factors. The stimulation 
strategy to maximize the theta power (i.e. Theta stimulation) was the most promising 
method among the tested stimulation strategies to decrease the frequency of seizures 
(Figure 27). The number of seizures was decreased by 43% on average with Theta 
stimulation (Figure 27B). When Theta stimulation was applied, the number of seizures was 
decreased in 4 out of 5 animals while maintained in only 1 animal compared to the baseline 
(Table 4). This result was contrasted with Sham where the seizure frequency decreased in 
2 animals, increased in 1 animal and unchanged in 2 animals (Table 2). The statistical 
significance, which was observed in the paired t-test between baseline and stimulation 
phases of Theta stimulation, was not observed anymore when the p-value was adjusted 
(Tukey’s HSD) to consider the multiple comparisons (Table 7).  A similar pattern was 
observed during the post-Theta stimulation phase. The seizure frequency was decreased 
about 30% compared to the baseline whereas the seizure frequency was increased by 17% 
during the post-Sham phase (Figure 27). The number of seizures was decreased in 3 
animals and unchanged in the other 2 animals during the post-Theta phase compared to the 
baseline (Table 4). Meanwhile, this pattern of the decreased seizure number was not 
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observed in post-Sham phase where the number of seizures decreased in 1 animal and 
increased in other 2 animals compared to the baseline (Table 2).  The other stimulation 
strategies did not decrease the seizure frequency more than Sham (Figure 27). A variability 
between trials was observed in the effect of 7Hz stimulation as the number of seizures 
maintained or increased in 2 animals respectively and decreased in the other animal 
compared to the baseline (Table 3). The optimal stimulation parameters to increase the 
PiSM score increased the seizure frequency during and after the stimulation (40% and 63% 
respectively) compared to the baseline (Figure 27B).  
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Figure 27. The number of seizures per hour (i.e. seizure frequency) to compare the 
effectiveness of the stimulation strategies. A. The raw seizure frequency with the 
standard deviation (error bar). B. The seizure frequency normalized to the baseline 





Table 2. The raw number of seizures for testing Sham 
Number of seizures in 1 hour (normalized number): Sham 
Rat ID Session order Baseline Stimulation Post 
1 2 2 (0) 4 (1) 3 (0.5) 
2 2 2 (0) 2 (0) 2 (0) 
3 3 1 (0) 1 (0) 2 (1) 
4 1 3 (0) 2 (-0.33) 1 (-0.67) 
5 4 1 (0) 0 (-1) 1 (0) 
 Mean ± std 1.8±0.75 (0±0) 1.8±1.33 (-0.07±0.65) 1.8±0.75 (0.17±0.56) 
 
Table 3. The raw number of seizures for testing 7Hz stimulation 
Number of seizures in 1 hour (normalized number): 7Hz 
Rat ID Session order Baseline Stimulation Post 
1 1 3 (0) 4 (0.33) * 
2 3 1 (0) 2 (1) 0 (-1) 
3 2 1 (0) 1 (0) 1 (0) 
4 4 2 (0) 1 (-0.5) 2 (0) 
5 3 1 (0) 0 (0) 0 (0) 
 Mean ± std 1.6±0.8 (0±0) 1.6±1.36 (0.16±0.49) 0.75±0.83 (-0.25±0.43) 
 
Table 4. The raw number of seizures for testing Theta stimulation 
Number of seizures in 1 hour (normalized number): Theta 
Rat ID Session order Baseline Stimulation Post 
1 4 6 (0) 3 (-0.5) 4 (-0.33) 
2 1 6 (0) 5 (-0.17) 2 (-0.67) 
3 4 1 (0) 1 (0) 1 (0) 
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Table 4 continued 
4 2 4 (0) 2 (-0.5) 2 (-0.5) 
5 2 2 (0) 0 (-1) 2 (0) 
 Mean ± std 3.8±2.04 (0±0) 2.2±1.72 (-0.43±0.34) 2.2±0.98 (-0.3±0.27) 
 
Table 5. The raw number of seizures for testing PiSM stimulation 
Number of seizures in 1 hour (normalized number): PiSM 
Rat ID Session order Baseline Stimulation Post 
1 3 1 (0) 3 (2) 4 (3) 
2 4 2 (0) 2 (0) 2 (0) 
3 1 1 (0) 1 (0) 1 (0) 
4 3 2 (0) 2 (0) 1 (-0.5) 
5 1 1 (0) 1 (0) * 
 Mean ± std 1.4±0.49 (0±0) 1.8±0.75 (2±1.22) 2.5±1.5 (0.63±1.39) 
 
Table 6. Three-way ANOVA for the raw and normalized number of seizures 
ANOVA: Raw number of seizures in 1 hour 
Source F Prob>F 
Experimental phase (baseline/stimulation/post stimulation)  0.92 0.4148 
Stimulation strategy 6.53 0.0025 
Animal 16.56 <0.0001 
Experimental phase*Stimulation strategy 2.15 0.0874 
Experimental phase*Animal 1.93 0.1065 
Stimulation strategy*Animal 1.75 0.1241 
ANOVA: Normalized number of seizures in 1 hour 
Source F Prob>F 
Experimental phase (baseline/stimulation/post stimulation)  0.18 0.6767 
Stimulation strategy 5.49 0.0173 
Animal 5.45 0.0136 
Experimental phase*Stimulation strategy 0.74 0.5515 
Experimental phase*Animal 1.78 0.2089 
Stimulation strategy*Animal 2.58 0.0715 
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Table 7. P-values from paired t-test and Tukey's honset significant difference 
criterion post-hoc test. 
Raw number of seizures in 1 hour 
Comparison Raw P-value Adjusted P-value 
Sham-baseline Sham-stimulation 1 1 
Sham-baseline Sham-post 1 1 
Sham-stimulation Sham-post 1 1 
7Hz-baseline 7Hz-stimulation 1 1 
7Hz-baseline 7Hz-post 0.1817 1 
7Hz-stimulation 7Hz-post 0.7117 1 
Theta-baseline Theta-stimulation 0.0349 0.1249 
Theta -baseline Theta-post 0.0993 0.1249 
Theta-stimulation Theta-post 1 1 
PiSM-baseline PiSM-stimulation 0.3739 0.9995 
PiSM-baseline PiSM-post 0.6042 0.9916 
PiSM-stimulation PiSM-post 1 1 
Normalized number of seizures in 1 hour 
Comparison Raw P-value Adjusted P-value 
Sham-stimulation 7Hz-stimulation 0.9080 1 
Sham-stimulation Theta-stimulation 0.2688 0.9183 
Sham-stimulation PiSM-stimulation 0.1079 0.7863 
Sham-post 7Hz-post 0.2560 0.7362 
Sham-post Theta-post 0.1148 0.7863 
Sham-post PiSM-post 0.6130 0.8049 
 
6.3.2 Total seizure time 
The total seizure time was calculated by measuring and summing the length of all 
seizures during the one-hour recording, and it was used to identify the effect of the 
stimulation strategies. The P-values from the statistical analyses are shown in Table 12 and 
Table 13. The 3-way ANOVA test for the raw total seizure time showed that the stimulation 
strategy had effects, and the same test for the normalized total seizure time showed that the 
animal subject had effects (Table 12, α=0.05). The results of ANOVA can be interpreted 
as that each stimulation strategy induced different effects on the seizure frequency and the 
variability between subjects made the animal one of significant factors. Similarly to the 
seizure frequency test results, there was a tendency of decreased total seizure time when 
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Theta stimulation was applied while it was not observed by the other stimulation strategies 
or Sham (Figure 28). First, the total seizure time during the stimulation phase in Sham trial 
showed zero average change resulted from an increase in 2 animals and a decrease in 3 
other animals (Figure 28B, Table 8). Meanwhile, the total time of seizures decreased by 
43% during Theta stimulation and 36% during the post-Theta stimulation phase (Figure 
28B). It was observed that the total time was decreased in all five animals for both Theta 
stimulation and post-Theta stimulation compared to the baseline (Table 10). The statistical 
significance, which was observed in the paired t-test between baseline and stimulation 
phases of Theta stimulation, was not observed anymore when the p-value was adjusted 
(Tukey’s HSD) to consider the multiple comparisons (Table 13).  Again, a variability 
between subjects in the effect of 7Hz stimulation was observed. An increase of the total 
seizure time was observed in 2 different animals and a decrease was observed in 2 animals 
which resulted in 7% decrease overall (Table 9, Figure 28B). Although there were not 
many trials, the total time was decreased for all 3 animals during the post-7Hz stimulation 
phase (Table 9). PiSM stimulation worsened the epileptic symptom as the total time of 
seizures was increased for all animals, that had a clean recording without motion artifacts, 
during the stimulation (Table 11).  
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Figure 28. The total seizure time per hour to compare the effectiveness of the 
stimulation strategies. A. The total time of seizures per hour with the standard 
deviation (error bar). B. The total seizure time normalized to the baseline to identify 





Table 8. Total seizure time for testing Sham. 
Total seizure time in 1 hour (normalized time): Sham 
Rat ID Session order Baseline Stimulation Post 
1 2 66 (0) 152 (1.3) * 
2 2 90 (0) 96 (0.07) 63 (-0.3) 
3 3 57 (0) 56 (-0.02) 120 (1.11) 
4 1 120 (0) 77 (-0.36) * 
5 4 40 (0) 0 (-1) * 
 Mean ± std 74.6±27.9 (0±0) 76.2±49.7 (0±0.75) 91.5±28.5 (0.41±0.71) 
 
Table 9. Total seizure time for testing 7Hz stimulation. 
Total seizure time in 1 hour (normalized time): 7Hz 
Rat ID Session order Baseline Stimulation Post 
1 1 100 (0) 173 (0.73) * 
2 3 57 (0) 84 (0.47) 0 (-1) 
3 2 * * 69 (*) 
4 4 94 (0) 51 (-0.46) 90 (-0.04) 
5 3 85 (0) 0 (-1) 0 (-1) 
 Mean ± std 84±16.5 (0±0) 77±63 (-0.07±0.7) 39.8±40.4 (-0.68±0.45) 
 
Table 10. Total seizure time for testing Theta stimulation. 
Total seizure time in 1 hour (normalized time): Theta 
Rat ID Session order Baseline Stimulation Post 
1 4 201 (0) 154 (-0.23) 117 (-0.42) 
2 1 380 (0) 259 (-0.32) 111 (-0.71) 
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Table 10 continued 
3 4 59 (0) 53 (-0.1) 52 (-0.12) 
4 2 147 (0) 74 (-0.5) 70 (-0.52) 
5 2 168 (0) 0 (-1) 159 (-0.05) 
 Mean ± std 191±105.6 (0±0) 108±90.3 (-0.43±0.31) 101.8±37.6 (-0.36±0.25) 
 
Table 11. Total seizure time for testing PiSM stimulation. 
Total seizure time in 1 hour (normalized time): PiSM 
Session number Rat ID Baseline Stimulation Post 
1 3 34 (0) 88 (1.6) 120 (2.53) 
2 4 103 (0) 138 (0.34) 132 (0.28) 
3 1 * * 120 (*) 
4 3 79 (0) 80 (0.01) 0 (-1) 
5 1 86 (0) * * 
 Mean ± std 75.5±25.5 (0±0) 102±25.7 (0.65±0.69) 93±53.9 (0.6±1.46) 
 
Table 12. Three-way ANOVA for the raw and normalized number of seizures. 
ANOVA: Raw total seizure time in 1 hour 
Source F Prob>F 
Experimental phase (baseline/stimulation/post stimulation)  0.4 0.6752 
Stimulation strategy 4.04 0.0289 
Animal 2.82 0.0659 
Experimental phase*Stimulation strategy 1.87 0.1574 
Experimental phase*Animal 2.09 0.1093 
Stimulation strategy*Animal 2.17 0.0845 
ANOVA: Normalized total seizure time in 1 hour 
Source F Prob>F 
Experimental phase (baseline/stimulation/post stimulation)  0.52 0.5043 
Stimulation strategy 3.74 0.1108 
Animal 7.48 0.0314 
Experimental phase*Stimulation strategy 0.36 0.785 
Experimental phase*Animal 1.08 0.4561 
Stimulation strategy*Animal 1.43 0.3637 
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Table 13. P-values from paired t-test and Tukey's honset significant difference 
criterion post-hoc test. 
Raw total seizure time in 1 hour 
Comparison Raw P-value Adjusted P-value 
Sham-baseline Sham-stimulation 0.9486 1 
Sham-baseline Sham-post 0.7578 0.9995 
Sham-stimulation Sham-post 0.8031 0.9996 
7Hz-baseline 7Hz-stimulation 0.8572 1 
7Hz-baseline 7Hz-post 0.1770 1 
7Hz-stimulation 7Hz-post 0.7195 1 
Theta-baseline Theta-stimulation 0.0426 0.2351 
Theta -baseline Theta-post 0.1354 0.1693 
Theta-stimulation Theta-post 0.9058 1 
PiSM-baseline PiSM-stimulation 0.1926 1 
PiSM-baseline PiSM-post 0.8273 0.9987 
PiSM-stimulation PiSM-post 0.6390 1 
Normalized total seizure time in 1 hour 
Comparison Raw P-value Adjusted P-value 
Sham-stimulation 7Hz-stimulation 0.7655 1 
Sham-stimulation Theta-stimulation 0.2059 0.9056 
Sham-stimulation PiSM-stimulation 0.0097 1 
Sham-post 7Hz-post * * 
Sham-post Theta-post 0.2952 0.7606 
Sham-post PiSM-post * * 
 
6.4 Discussion 
Two stimulation strategies by using the novel data-driven surrogate approach were 
applied to evaluate their therapeutic effectiveness. One strategy applied the optimal 
parameters to increase the hippocampal theta power (Theta stimulation) and the other 
strategy applied the optimal stimulation parameters to increase the output of PiSM (PiSM 
stimulation) for inducing the estimated anti-seizure neural state. An empirically selected 
parameter set as a conventional approach as well as sham stimulation were also tested for 
the comparison reason. Among them, only Theta stimulation showed a potential to be  a 
novel method for suppressing the seizure as the frequency and the total seizure time during 
the stimulation decreased (4 and 5 out of 5 animals respectively, Table 4 and Table 10).  
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7Hz stimulation where the parameter set was empirically selected showed a high variability 
between subjects/trials as expected. PiSM stimulation did not suppress the seizure, so PiSM 
is not the desired surrogate for the data-driven approach. 
In almost every animal, the optimal parameters to increase the hippocampal theta 
suppressed seizures by reducing the frequency and the total seizure time. In Chapter 4, the 
hippocampal theta showed two contradictory characteristics according to two neural state 
models. The hippocampal theta showed the pro-seizure characteristic during 
epileptogenesis whereas it showed the anti-seizure characteristic during the pre-ictal 
period.  The result of suppressed seizures suggests that the increased hippocampal theta by 
MS optogenetic stimulation more likely represents the anti-seizure neural state.  
PiSM stimulation did not suppress seizures, and there are two hypotheses which 
can explain the failure of PiSM stimulation. First, PiSM stimulation might have modulated 
some key neural features in the undesired way and resulted in inducing the pro-seizure 
state. As shown in Chapter 5, a combination of a few different neural features forms the 
output of PiSM. Therefore, it is possible that the modulation of PiSM output brought some 
features in the anti-seizure mode and the other features in the opposite mode. If one of the 
features in pro-seizure mode was the key, which is causal to seizures, the seizure 
susceptibility was likely to be promoted. The second potential hypothesis is that what high 
scores of PiSM represent is the pro-seizure neural state. PiSM was built by classifying 
neural features between the pre-ictal and inter-ictal periods, and the output of PiSM during 
the pre-ictal period was higher than during the inter-ictal period. If what PiSM describes is 
an effort of the brain to suppress the seizure, delivering the stimulation which increases the 
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output of PiSM likely suppressed the brain’s activity to resist against a seizure. This 
possibly resulted in the increase of the seizure frequency and the total seizure time.  
A few modifications can be considered to improve the effectiveness of the data-
driven surrogate approach. The first is to develop more precise data-driven surrogate 
models for better describing the pathological neural states. PiSM is a linear classifier which 
is not able to describe complex behaviors of hippocampal neural features during the pre-
ictal period. In addition, estimating the neural state may have suffered from a lack of 
information since only a limited feature set (i.e. power spectral density, coherence and 
phase coherence) was used to describe the neural state. A deep learning model such as a 
convolutional neural network is expected to better characterize the neural states with its 
ability to describe non-linear relationships and incorporate neural features from a wider 
space (e.g. time domain117). Second, the modulation of the neural state can be improved by 
leveraging state-dependent optimization. The state-dependency of MS optogenetic 
stimulation effect on the theta power or PiSM score was presented in Chapter 5. Given that 
a rat undergoes frequent natural state transitions, it is highly likely that the optimal 
stimulation parameter loses its effectiveness during the experiment. As explained in the 
Chapter 5 discussion, the state-dependent Bayesian optimization which incorporates the 
pre-stimulation state can improve the effectiveness of the stimulation. The state-dependent 
optimal parameter may effectively maintain the anti-seizure neural state or induce a 
transition from the pro- to anti-seizure state. 
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CHAPTER 7. CONCLUSIONS 
7.1 Summary and conclusions 
A novel data-driven approach for optimizing the neuromodulation more effectively 
and efficiently by investigating the stimulation effect on surrogate neural state models is 
presented. The conventional approach for preclinical studies requires a large amount of 
time and resources to find effective stimulation parameters and often fails due to the inter-
subject variability in stimulation effect. To solve the listed limitations of the conventional 
approach, I implemented and demonstrated a variety of machine learning techniques to 
explore the stimulation effect, to describe the pathological neural states and to optimize the 
stimulation parameters. First, I have exhaustively explored the effect of exciting or 
inhibiting different neuronal subpopulations in the normal rat medial septum (MS) by using 
optogenetic stimulation. As a result, MS optogenetic stimulation using hSynapsin promoter 
(non-selective) in combination with Channelrhodopsin-2 was well suited for modulating 
electrophysiological activity of the hippocampus. Second, I demonstrated in-vivo Bayesian 
optimization (BaO) algorithm to quickly find the subject-specific optimal stimulation 
parameters to effectively modulate the hippocampal neural features. Third, I built data-
driven neural state models to estimate a seizure susceptibility based on electrophysiological 
recordings. Two models were built to describe neural state transitions during 
epileptogenesis and pre-ictal period. The output of the model played a surrogate role by 
providing a metric which was regulated through MS optogenetic stimulation. Fourth, the 
BaO algorithm was modified to be applied for epileptic animals where abnormal activities 
(e.g. inter-ictal spikes) present. It was demonstrated that the hippocampal theta power and 
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the output of pre-ictal state model (PiSM) were effectively modulated with the optimal 
stimulation parameters found by the modified BaO algorithm. Lastly, I tested whether 
modulating the surrogate neural states affected the symptom of epilepsy (i.e. seizure). The 
treatment efficacy of a data-driven surrogate approach was compared to the stimulation 
with the empirically selected parameter. The subject specific stimulation parameters to 
maximize the hippocampal theta (4-10Hz) power was more effective than the empirically 
selected parameter (7Hz) for the seizure suppression. The optimal modulation of PiSM 
output for inducing the anti-seizure neural state did not suppress seizures. From the results 
of this thesis work viewed together, I conclude that the subject specific optimal parameters 
to modulate the surrogates for inducing the anti-seizure neural state is a potential novel 
neuromodulation method for epilepsy treatment. 
The data-driven surrogate approach was developed by applying various machine 
learning and statistical techniques to improve the current neuromodulation technologies. 
There are two main advantages of the novel data-driven surrogate approach. First, it 
provides a new approach for preclinical study to save time and resources and minimize the 
side-effect. We demonstrated the effectiveness of Bayesian optimization in stimulation 
parameter search to modulate the neural state surrogates. By solving the issue that finding 
a stimulation parameter set from the enormous space with the limited time and resources, 
this approach can accelerate the process for developing a novel neuromodulation treatment. 
Second, it provides a chance to find the underlying mechanism of epilepsy by investigating 
the electrophysical activity in the hippocampus. Most of studies focus on either activity 
change induced by pathological symptom or brain stimulation. The data-driven surrogate 
approach, however, focuses on both by modulating the neural features which represents 
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the pathological neural state with the brain stimulation. Therefore, applying this approach 
will identify features from the electrophysiological recording as well as their causal 
relationship to the disease.  
Data driven surrogate approach can be applied for not only epilepsy but also other 
diseases where brain signal recording and stimulation is performed. Therefore, this project 
will be a milestone which suggest the way to go for preclinical and clinical studies in 
neurology and psychiatry fields.  
7.2 Alternative approaches and future direction 
A few alternative methods can be considered to improve the therapeutic efficacy of 
the data-driven approach with MS optogenetic stimulation. First, it is needed to develop 
more precise data-driven surrogate models for better describing the pathological neural 
state. The pre-ictal state model (PiSM), a surrogate neural state model used for the seizure 
treatment, was a linear classifier which is not able to describe complex non-linear 
relationship between pre-ictal state and hippocampal neural features. In addition, 
estimating the neural state may have suffered from a lack of information since only a 
limited feature set (i.e. power spectral density, coherence and phase coherence) was used 
to describe the neural state. We expect to improve the ability to characterize the neural 
states by leveraging a deep learning model. A convolutional neural network (CNN) model 
is a feedforward neural network that implements parameter sharing facilitated by the 
convolution operations. The CNN model is an appropriate choice to use the time-domain 
LFP as an input as it can identify key temporal features in the pre-ictal period regardless of 
location within a given time window. In addition, the CNN model is well suited for the 
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multi-channel recording used in our experimental design by using a two-dimensional input 
(channel ×  LFP sample). Therefore, building the CNN model will provide a better 
estimation of pathological neural states by minimizing the loss of information in the 
hippocampal neural activities.  
Second, a wider stimulation parameter space needs to be explored. Clear 
differences in the stimulation effect between single-frequency standard pulse and nested-
pulse train were shown in Chapter 3. Therefore, extending the parameter space may enable 
an observation of new stimulation effects. Various patterns of the stimulation such as 
sinusoidal, Poisson or randomly distributed118 pulse have not been tested yet. In addition 
to widening the stimulation parameter space, testing different neuronal subpopulation as a 
target of optogenetic stimulation needs to be considered. Applying excitation to MS 
neurons transfected with calcium/calmodulin-dependent protein kinase IIα (CamKⅡα) 
promoter, which selectively transfects the glutamatergic neurons in MS63,64, was also able 
to effectively modulate the hippocampal neural activities. As modulating different MS 
subpopulations is expected to induce different effects in the hippocampus, the new 
promoter may provide a better target to induce anti-seizure neural state in the hippocampus. 
Third, it needs to be investigated whether a duration of the stimulation as another 
parameter can affect the effectiveness of stimulation for seizure treatment. In this project, 
we tested one-hour continuous stimulation to suppress seizures. However, a previous in 
vitro study showed that the effectiveness of optogenetic stimulation to suppress seizures 
significantly dropped after first 12 seconds of the stimulation119. In another in vivo study 
presented by Osawa-et-al a pattern of the causality between hippocampal regions was 
different after a few seconds of the stimulation from the beginning of the stimulation120. 
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Desai-et-al also showed that intermittent electrical stimulation (2-minute on and 2-minute 
off) in the hippocampus was effective to suppress seizures30. Based on these previous 
studies, intermittent stimulation can improve the therapeutic efficacy by avoiding the 
decrease in the stimulation effectiveness. By optimizing a duration of stimulation on/off, 
intermittent stimulation may effectively induce anti-seizure neural state. In addition, a 
closed-loop approach which applies the stimulation only when a seizure is predicted can 
be an alternative to the current approach. Other studies suggested a habituation of the brain 
that the effect of neural stimulation may be cumulative, reaching maximum efficacy after 
a certain duration of stimulation delivered10. Although it is still not clearly identified, a 
long continuous stimulation may also induce a cognitive function deficit as a side effect121–
124. A closed-loop approach can be a solution for these issues by applying the stimulation 
only when it is necessary. As responsive neural stimulation which delivers stimulation 
when a seizure is detected already presented successful cases, an improved closed-loop 
approach with the seizure prediction is expected to provide a better outcome. 
It is needed to interpret the mechanism of treatment by investigating which 
neuronal pathway in the septo-hippocampal circuit is involved in the seizure suppression 
as a response to MS optogenetic stimulation. Given the complex anatomical connections 
in the septo-hippocampal circuit, it is extremely hard to predict the travel path of the 
neuronal activity induced by MS optogenetic stimulation. In addition, the selection of 
stimulation parameters may affect a pathway of neuronal signaling. The post-mortem 
immunohistological analyses can provide a method to identify which neuronal 
subpopulations are affected by the MS optogenetic stimulation. This study will help to 
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understand the underlying mechanisms of disease treatment through the neuromodulation 
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